Brain Sensitivity to Barbiturates and Brain Gamma-Aminobutyric Acid by Patel, Girish J.
University of Rhode Island 
DigitalCommons@URI 
Open Access Master's Theses 
1972 
Brain Sensitivity to Barbiturates and Brain Gamma-Aminobutyric 
Acid 
Girish J. Patel 
University of Rhode Island 
Follow this and additional works at: https://digitalcommons.uri.edu/theses 
Recommended Citation 
Patel, Girish J., "Brain Sensitivity to Barbiturates and Brain Gamma-Aminobutyric Acid" (1972). Open 
Access Master's Theses. Paper 217. 
https://digitalcommons.uri.edu/theses/217 
This Thesis is brought to you for free and open access by DigitalCommons@URI. It has been accepted for inclusion 
in Open Access Master's Theses by an authorized administrator of DigitalCommons@URI. For more information, 
please contact digitalcommons@etal.uri.edu. 
I 
BRAIN SENSITIVITY TO BARBITURATES Al';D BRA.IN 
GAMMA-AMINOBUTYRIC ACID 
BY 
GIRISH J. PATEL 
A TP...ESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE 
REQUIREMENTS FOR THE DEGREE O:t<· 
MASTER OF SCIENCE 
IN 
PHAIDL\COLOGY A.ND TOXICOLOGY 
UNTVERSITY O:F· RHODE TSLA:N"D 
1972 
MASTER OF SCIENCE THESIS 
OF 
GIRISH .J. PATEL 
Approved: 
Thesis Committee: 
Dean of the Gradua te School 
l..'1UVERSITY OF RHODE I Si..,_.\....·r-m 
1972 
ABSTRACT 
The correlation between alteration in brain sensi-
tivity to barbiturates and changes in brain gamma-amino-
butyric acid levels was investigated. The following con-
ditions were utilized to alter the brain sensitivity of 
mice or rats to barbiturates, 1) exposure to hypobaric 
hypoxia, 2) septal lesions, 3) tr~atment with desipramine, 
sodium nitrite or pargyline, 4) social deprivation, and 5) 
abrupt withdrawal following chronic barbiturate or ethanol 
administration. The first three of the s e conditions h a ve 
been known to increase the brain sens i tivi t y to barbi t u-
rates, while the last two conditions are known to decrease 
the sensitivity of brain neurons to barbiturates. The brain 
levels of gamma-aminobutyric acid were determined after the 
above treatments. Wherever necessary, the mechanism of 
alteration in gamma-aminobutyric acid was investigated by 
. measuring activities of the enzymes, glutamic acid de-
carboxylase and gamrna-aminobutyric acid transaminase. 
Acute Hypoxia 
Exposure of mice to hypobaric hypoxia (364 mm Hg , 
p02 = 76 rrun Hg ) for JO or 60 minutes a t 22 o r J0°C a mb i ent 
temperat ure, produced elevation in brain lev el s of gamma -
aminobutyric acid. Only hypoxia was found to aff ect brain 
i 
gamma-aminobutyric acid. Ambient temperature or duration 
of hypoxia exposure did not affect or interact with the 
effect of hypoxia on brain gamma-aminobutyric acid. These 
data suggest that hypoxia induced-elevation in brain gamma-
aminobutyric acid may lower the threshold of brain neurons 
to drug induced depression. 
Septal Lesions 
Bilateral lesions of the septal area markedly po-
tentiated narcosis due to barbital suggesting that altera-
tion in neuronal excitability had taken place. There was 
no difference in the levels of brain gamma-aminobutyric 
acid between the septal rats and sham-operated or normal 
control rats. Therefore, the effect of septal lesions on 
the brain sensitivity does not appear to be related to al-
teration in brain gamma-aminobutyric acid. 
Drug Treatments 
Desipramine, ambient temperature and their inter-
action had a significant effect on brain gamma-aminobutyric 
acid. At 22°C, desipramine produced hypothermia and ele-
vated brain gamma-aminobutyric acid levels. At J0°C am-
bient temperature desipramine ceased to reduce body tern-
perature and brain gamma-aminobutyric acid. In mice 
treated with desipramine at the lower ambient temperature , 
there was a dose-response relationship between the amount 
of drug administered and the elevation in brain gamma-amino-
ii 
butyric acid. Hypothermia due to desipramine appears to be 
important in the elevation o:f brain ganuna-aminobutyric acid. 
These :findings suggest that reduced brain excitability due 
to high garnma-aminobutyric acid may alter the response of 
brain neurons to barbiturates. 
At 22°C, sodium nitrite produced hypothermia and 
raised brain levels of gamma-aminobutyric acid. At J0°C am-
bient temperature sodium nitrite ceased to af:fect body tem-
perature and brain gamma-·arninobutyric acid. Even though, 
hypothermia due to sodium nitrite seems to be important in 
elevation of gamma-arninobutyric acid, elevation of gamma-
arainobutyric acid is the result o:f sodium nitrite's ability 
to produce hypoxia. 
Pargyline induced potentiation of narcosis due to 
barbital was greater at 22°C than at J0°C ambient tempera-
ture. This suggested that pargyline alters the neuronal 
sensitivity to barbiturates at both the ambient tempera-
tures. Pargyline also produced hypothermia and elevated 
brain ga.mma-aminobutyric acid at both the ambient tempe ra-
tures. There was a greater degree of reduction in body 
temperature and elevation in brain gamma-aminobutyric acid 
when mice were treated with pargyline at 22°C. ::!:n pargyline 
treated mice, at 22°C, there was a dose-re sponse relation-
ship betwe en che amount of drug adminis t ered and the d~ ­
gree of elevat .i .on in brain garnrna-c>.minobutyric acid. 'l'hesH 
observations indicate that pa::.~gylilli~ indu~ed hypothernia 
causes elevation in brain gan.u"'Ila-aminobutyric acid. Further~ 
the increased concentrations of brain ganuna-aminobutyric 
acid may in turn lower the threshold of brain neurons to 
barbiturates. 
Social Deprivation 
Chronic deprivation of social stimuli lowered brain 
gamma-aminobutyric acid levels, decreased the activity of 
the gamma-aminobutyric acid synthesizing enzyme, glutamic 
acid decarboxylase and reduced total protein content in the 
brain. The activity of the gamrna-aminobutyric acid degrad-
ing enzyme, gamma-aminobutyric acid transaminase, remained 
unaltered. These data suggest that reduced concentrations 
of gamma-aminohatyric a.cid might have raised ar::n1sa.l levels 
of the deprived mice such that their ce~tral nervous system 
susceptibility to drugs was altE:Yed. 1'urther, !'{-) duced 
levels of gamma-aminobutyric acid were true reflection::: of 
glutamic acid decarboxylase. 
Drug Withdrawal 
The fluid intake of mice was restricted to increas-
ingly concentrated solutions of phenobarbital for four 
weeks. Abrupt withdrawal resulted in convulsive activity 
in response to an auditory stimulation. There was no alter-
ation in brain levels of garmna-aminobutyric acid in any o!~ 
the groups tested. These data suggest that brain gamrna -
aminobutyric acid was not involved in the alteration of 
neuronal sensitivity following barbiturate withdrawal . 
iv 
Intoxicating blood levels of ethanol were maintained, 
by stabilizing blood ethanol-levels with daily injections of 
pyrazole, for 96 hours in mice housed in an atmosphere of 
ethanol vapour. On removal from the ethanol, mice developed 
withdrawal signs . The signs were graded to indicate the 
time course and intensity of the withdrawal syndrome. Eight 
and twenty-four hours following ethanol withdrawal mice were 
tested with barbital. Both the groups showed marked reduc-
tion in narcosis due to barbital. These observations sug-
gested that ethanol withdrawal heightened the threshold of 
brain neurons to drug induced depression. The brain levels 
o1' gamma-aminobutyric acid were found to be lowered follow-
ing eight hours of ethanol withdrawal. This indicates that 
lower than normal brain gamma-aminobutyric acid may cause an 
increase in neuronal excitability, which is revealed upon 
administration of the barbiturate. 
v 
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INTRODUCTION 
Various factors in the environment have been known to 
affect physiological processes within the organism resulting 
in altered pharmacological response. Factors such as ambi-
ent temperature (Chance, 1957), atmospheric pressure 
(Bernardini, 1 969), population density (Chance and Mackin-
tosh, 1962) and seasonal variations (Heller et al., 1957) 
may influence the onset, potency or duration of action of a 
drug thus altering the resultant pharmacodynamic activity. 
Treatments l i ke hypoxia (Robinson et al., 1968), administra-
tion of sodium nitrite (Baumel et al., 1971) or desipramine 
(Shah and Lal, 1971), or prolonged social deprivation 
(Baurnel tl al., 1970a) have been reported to alter the CNS 
sensitivity to barbiturates. The other conditions which 
have been known to alter the neuronal sensitivity to barbi-
turates include, tolerance or physical dependence on bar-
biturates (Stevenson and Turnbull, 1970; Wahstrom, 1971) 
a n d decerebration or lesions of the septal area (Seguin and 
St avraky, 1957; Harvey tl al., 1964). 
The alteration in neuronal sensit i vity can be de-
fined as an al t ered pharmacological response of the neuronal 
tissue to s i milar drug concentra tions . Al t eration of 
pharmacological response due to changes in the metabolism 
of the drug or the rate of entry of the drug into brai n is 
not included in thi s definition. 
I . 
I 
I 
~ 
I 
The alteration in neuronal sensitivity to drugs could 
sometimes be therapeutically beneficial. However, undesir-
able response to a drug treatment because of alteration in 
neuronal sensitivity to drugs is not very unconunon either. 
A better understanding of the mechanisms underlying these 
changes may aid in the development of preventive methods to 
counteract undesirable effects induced either by a drug 
treatment or an environmental extreme. 
It is now well accepted that GABA plays a role as a 
specific inhibitory transmitter in the manunalian CNS 
(Davidoff, 1972; Ehinger and Falck, 1971). GABA has also · 
been shown to have non-specific depressant action, when ap-
plied directly to the brain of mamnals (Bindman et al., 
1962). Further, of all the depressant amino-acids, GABA 
occurs in largest amounts and it is uniquely present in 
the nervous tissue (Roberts, 1956). By virtue of these 
characteristics, alteration of GABA levels in the neuronal 
environment may be expected to alter the threshold of brain 
neurons to drug induced narcosis. There are several points 
that support this suggestion. They are sununarized as be-
low: 
1. Treatments like desipramine (Shah and Lal, 1971), so-
dium nitrite or hypoxia ( Baumei et al., 1971, 1970b) caus e 
hypothermia and potentiate barbitura te induced n a rcosis at 
22°C but have no such effect at J0°C ambient tempera t ure. 
Shah and Lal (1971) noted t h e finding of Oja ~al. (1968) 
that hypothermia elevates the brain levels of GABA. 
8 
2. Sodium nitrite induced potentiation of barbiturate nar-
cosis was reversed by hyperbari c oxygen (OHP ) (Baumel et al., 
1971), a treatment known to cause marked reduction in brain 
GABA (wood et al., 1967). 
J. Hypoxia increased brain GABA ( Woo d et al., 1968), which 
enhanced the depression of brain neurons so that barbiturate 
induced-narcosis was potentia.ted (Baumel et al., 1970b). 
Moreover, hypoxia antagonized convulsions induced by semi-
carbazide or methionine sulphoxamine (Eaumel et al., 1969a, 
1969b), drugs known to decreas e:: brain levels of GABA (Killam 
and Bain, 1967; Roberts and Frankel, 1951; Lamar and Sellin-
ger, 1965). 
This investigation was undertaken to investigate the 
correlation between alteration in brain sensitivity to bar-
biturates and changes in brain GABA-leYels. 
Based upon the hypothesis, the predictions which were 
undertaken for testing are: 
1. That brain GABA-levels will be elevated by a variety of 
conditions known to increase the CNS sensitivity to barbi -
turates, these conditions will include: 
a) exposure to hypobaric hypoxia 
b) septal lesions 
c) treatment with desipramine, sodium nit rite or 
pargyline 
2. That brain levels of' GABA will be decreased by condi-
tions kno;vn to 101rnr the CNS sensitivity to barbiturates, 
these conditions wil l include: 
9 
a) social deprivation 
b) abrupt withdrawal following chronic barbiturate 
or alcohol administration 
It was therefore undertaken to subject the animals 
to all of the aforementioned conditions or treatments and 
then measure their brain GABA-levels, in order to estab-
lish that alteration of GABA-levels in the neuronal en-
vironment will alter the threshold of brain neurons to drug 
induced depression. 
LITERATURE SURVEY 
GABA 
10 
Gamma-aminobutyric acid first appeared in the lit-
erature in 1883 when the synthesis of a compound named 
"piperidinsaure" was reported (Baxter, 1970). But its 
presence in neurological tissue was not recognized until 
1950 (Roberts and Frankel, 1950; Awapara et al., 1950; 
Udenfriend, 1950). High levels of GABA a~e found in the 
peripheral nerves of crustaceans and in the central nervous 
system- brain, spinal cord and retina- of vertebrates. 
In the central nervous system of mammals the "GABA 
shunt" (Figure 1) represents an alternate pathway in the 
portion of the tricarboxylic acid cycle that leads from 
alpha-keto glutarate to succinate. The carbon chain of 
alpha-keto glutarate can be converted via glutamic acid 
and GABA to succinate and co2 (Baxter, 1970). The "GABA 
shunt" involves three enzymes, namely, glutamic acid de-
carboxylase (GAD), gamma-amino butyric acid- alpha-keto 
glutaric acid transaminase (GABA-T) and succinic semi-
aldehyde dehydrogenase (SSA-D) (Roberts and Kuriyama, 1968). 
The close correlation between the level of GAD and GABA, 
in almost a ll areas of brain tested, suggest that GAD is 
the only significant enzymatic pa thway leading to GABA in 
nerve tissue (Baxter, 1970). The major pathway of GABA 
----- ............. 
// "' 
i/ \ 
Oxalocetate oC.-Ketoglutarate 
Tricarboxylic 
Acid 
Cycle 1 
C.itrate Succinate 
'-
' 
......._ 
__,,,., 
/ 
/ 
GAD = L-GLUTAMATE DECARBOXYLASE 
GABA -T =GABA , GLUTAMATE TRANSAMINASE 
Gdh = L-GLUTAMATE DEHYDROGENASE 
SSAdh = SUCCINIC SEMIALDEHYDE DEHYDROGENASE 
3 GABA-T 
\ 
~ 
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GLUTAMATE 
2 
GAD 
GAMM.A -
AMINOBUTYRATE 
(GABA ) 
Figure 1. GAMMA-AMINOBUTYRIC ACID SHUNT. Pathways 2-4 represent the "GABA shunt" 
around pathway 1 of the tricarboxylic acid cycle. 
'""" 
'""" 
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degradation is via transamination with alpha-keto glutarate 
to form glutamate and succinic semialdehyde, GABA-T has been 
shown to be involved in this reaction (Baxter and Roberts, 
19 58). 
The enzyme L-glutarnic acid decarboxylase (GAD) is 
found only in the central nervous system, largely in gray 
matter and most highly concentrated in nerve endings (Balazs 
et al., 1966; Salganicoff and DeRobertis, 1965). On the 
other hand, GABA-alpha-keto glutarate transaffiinase (GABA-T) 
is found in high concentrations in the C)>'"toplasmic con-
stituent of the gray matter (Roberts and Kuriyama, 1968). 
Both GAD and GABA-T are vitamin B6 dependent enzymes (Bax-
te:!', l9'70). 
GABA as a S;.·-:!cific I nhibi to-ry 1:?.~ansm:!.tt~r and a Non-Specif-
ic Deoressant Substance 
GABA was established as a.n irL1libi tory "transmitter 
at the crustacean neuromuscular junction several years ago 
(Kravitz~ al., 1965; Otsuka et al., l966). Since then, 
evidence for GABA as a neurotransmitter in mammalian cen-
tral nervous system has rapidly grown. At present, GABA 
appears to be an important inhibitory transmitter in 
mammalian CNS. 
GABA in Crustacean Neuromuscular Junction: 
Inhibitory neurons o~ the lobster contain a large 
amount of GABA; its concentration in inhibi t ory axons is 
about 100 times hi gher t11an that in excitatory axons 
13 
{Kravitz et al., 1965). There is a remarkable parallel be-
tween the action of GABA on crayfish neuromuscular junction 
and that of neural i1iliibitory transmitter. For instance, 
both actions are antagonized by picrotoxin (Takeuchi and 
Takeuchi, 1965). Finally, it has been shown that GABA is · 
released from inhibitory nerves of the lobster in response 
to stimulation (Otsuka et al., 1966). 
--
GABA in Mammalian Brain 
The depressant effects of GABA on the mammalian CNS 
have also been intensively studied and efficiently demon-
strated in various laboratories. For example, the rapid 
and reversible depressant effects of GABA on electrical ac-
tivity in the cerebral cort ex were demonstrated by Iwama 
and Jasper (1957) and by Purpura et al. (19.57). A depres-
sant action of GABA on cortical r.eurons was also demon-
strated in the rat (Mahnke and Ward, 1960) and in surgical-
ly isolated (main circulation intact) cerebral cortex in 
the dog (Rech and Domino, 1960). Several other reports 
indicate that GABA, when applied directly to the brain o!~ 
mammals, has a no~-specific depressant action (Curtis and 
Watkins, 1960; Bhargava and Srivastava, 1964). 
Particularly good evidence for GABA as an in.hibttory 
neurotransmitter has been obtained in several areas of the 
mammalian brain, e.g., in cortical neurons (Krnjevic and 
Schwartz, 1967), Deiter's neurons (Obata et al., 1967; 
Otsuka, 1972) and cuneate nucleus of the brain stem (Galindo 
14 
et al., 1967). Recent reports by Davidoff (1972) and 
Ehinger and Falck (1971) further support the possibility that 
GABA is an inhibitory transmitter in the spinal-cord and the 
brain. 
Besides GABA, other inhibitory amino acids are also 
present in the brain, namely taurine, B-alanine, glycj_ne and 
alanine (Tallan et al., 1954), hypotaurine (Bergeret and 
Chatagne, 1954) and guanidini-acetic acid (Pisano and Uden-
friend, 1958). Nevertheless, of all the depressant amino 
acids, GABA occurs in largest amounts; moreover, it occurs 
uniquely in nervous tissue (Roberts, 1956). 
GABA and Convulsions 
Wolfe and Elliott (1962) have reviewed the evidence 
for the role of GABA in convulsions unde= a variety of con-
di tions. Since then, many correlative studies have been 
done, which can be summarized as follows: 
1. intravenous or intraperitoneal GABA protected against 
drug-induced convulsions in monkeys (Kopeloff and 
Chusid, 1965). 
2. in.tracisternal GABA suppressed seizures induced by in-
tracisternal L-glutamate and pyridoxal-5-phosphate 
(Wiechert and Herbst, 1966). 
J. intravenous GABA produced sleep in chicks before the 
development of the blood-brain barrier and protected 
against pentylenetetrazole induced convulsions in 1-
day-old chicks (Kobrin and Seifter, 1966). 
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4. Topical GABA inhibited the spontaneous epileptiform 
activity and diminished the amplitude of the surface 
negative wave of responses evoked by means of stimula-
tion to the olfactory bulb (Guerrero-Figueroa et al., 
1964). 
5. The systemic administration of L-glutamic acid and 
amino oxyacetic acid (AOA), both known to elevate 
brain levels of GABA, protected animals against audio-
genic seizures (Schlesinger et al., 1968). 
6. GABA hae also been observed to protect against audi-
genic seizures in. mice, whether applied directly to 
the cortex (Ballantine, 1963), or administered system-
ically (Pasquini, et al., 1968) . 
7. exposure of animals to hypobaric oxygen (OHP) decreased 
brain GABA and produced convulsions (Wood et al., 1963). 
GABA administration protected these animals against 
convulsions (Wood et al., 1963). 
ACUTE HYPOXIA 
The te:;-m "hypoxia" means decreased availability of 
oxygen to ~he cells of the body. This condition may be 
caused by pulmonary disease (Oswald and Fry, 1962), cir-
culatory insufficiency (Finley et al., 1962), anemias and 
tissue edema (Van Liere and Stickney, 1963). A common form 
of hypoxia encountered by aviators, as ·trcnauts and others 
working at high altitudes or in controlled gaseous environ-
ments is inadequate oxyg enatio!l of lungs due to a def·iciency 
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of oxygen in the atmosphere. 
Hypoxia Due to Reduced Barometric Pressure 
The total pressure of' all gases in the air (baromet-
ric pressure) decreases as one ascends to higher altitudes. 
At sea level or normal room atmosphere, barometric pressure 
averages 760 mm Hg and the pressure contributed by oxygen 
to the total pressure (partial pressure, po2 ) is 159 mm Hg. 
Since oxygen remains at slightly less than 21% of' the total 
gaseous atmosphere, the p02 will decrease with correspond-
ing decreases in total barometric pressure. Thus at 
10,000 ft. barometric pressure=523 mm Hg and p02=110 mm Hg, 
whereas at 19,000 ft. the barometric pressure is 365 mm Hg 
and p02=76 mm Hg, equivalent to a 10% oxygen atmosphere at 
sea level (760 mm Hg). 
Up to an elevation of approximately 10,000 ft. the 
p02 in the air is sufficient to maintain arterial oxygen 
saturation at about 90%. However, above 10,000 ft. ele-
vation, arterial oxygen saturation falls progressively to 
approximately 70% at 19,000 f't. and still lower at higher 
altitudes, severely reducing the supply of oxygen deliv-
ered by blood to the tissues (Folk, 1966). 
HyPoxia and Brain Sensitivity 
Baumel et al. (1969a; 1969b; 1969c; 1970b) have pre-
·sented evidence that exposure of mice to hypoxia (364 mm Hg, 
p02=76 mm Hg) increased the sensitivity of brain neurons to 
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drug induced dep~ession. The evidence can be summarized as 
follows; the hypo xic exposure: 
1. at 22°C and J0°C ambient temperature, significantly in-
creased the duration of ~arcosis due to barbital, 
pentobarbi tal, chloral hydrate and shortened the onset 
of narcosis due to barbital in mice. 
2. at 22°C ambient temperature, significantly lowered 
pentobarbital whole-body levels at awakening in mice. 
J. antagonized convulsions induced by, a) semicarbazide, 
methionine sulphoximine or m-fluorotyrosine, and b) 
intracerebral semicarbazide. 
The hypo x ic exposure at 22°C and J0°C ambient temper-
ature, decreased absorption of barbital-c14 from the site 
of injection but did not alter penetration of barbital-c14 
into brain. 
Baumel et al. (1970) also reported that the exposure 
of the animals to hypoxia at 22°C ambient temperature re-
sulted in significant reduction in body temperature and 
that this effect was abolished at J0°C ambient temperature. 
Hypoxia and GAnA 
Exposure to hypoxia (5-8% o2 ) f'or more than 10 min-
utes has been shown to elevate brain GABA significantly in 
the mouse, hamster, rat, guinea pig and rabbit, with maxi-
mum elevation occurring at 60 minutes and the GABA falling 
off gradually the reafter (Wood, 196 '"( ; Wood et al., 1968). 
Wood has al~o suggested that GAEA possibly plays a homeo-
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static role in brain metabolism in hypoxic condition (Wood, 
1967). 
SEPTAL LESIONS 
Septal Lesions and Brain Sensitivity 
Subcortical lesions may affect an animal's sensitivity 
to barbiturates. Heller et al. (1960) found that lesions in 
the septal area of the basal telencephelon in rats caused a 
J-to-4 fold increase in both thiopental and barbital induced 
narcosis as compared with normal controls. The septal le-
sions also reduced the time for induction of narcosis by 
barbital by one-half (Harvey et al., 1964). This increase 
in barbiturate sensitivity has been sho-v.rn to be specific to 
septal regions since lesions of comparable size in cortex 
and in caudate nucleus do not significantly alter barbitu-
rate induced narcosis (Harvey et al., 196J). The increased 
sensitivity of the central nervous system to barbiturates 
could not be attributed to the effects of lesions on body 
weight, temperature regulation, drug ILletabolism, adrenal 
function or total brain levels of the drug (Roth and 
Harvey, 1968). 
Brain Lesions and Chemical ChangP-s 
Many of" the lesion studies done in connection with 
barbiturate ac <;ion have been reported to produce substan-
tial decreases in b:ra.in· · concentration of s erotonin, nore-
pinephrine and d.opamiir..e (He.:~_e r ~ al, , 196.2); H8.rvey et al., 
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1963; Harvey, 1965; Simpson et al., 1967). 
Harvey (1965) suggested that increase in sensitivity 
to a drug after subcortical lesions (Septal or dorsomedial 
tegmentum) may be due to the effects of the lesions on 
chemical processes in the remaining portions of the brain 
which are both similar to and additive with the effects of 
the drug. 
DRUG TREATMENTS 
Sodium Nitrite 
A great many substances such as nitrites, phenacetin, 
acetanilide, sulfanilamide, nitrobenzene and analin~ can 
produce mathemoglobinemia (Bodansky, 1951). Methemoglobin 
cannot carry oxygen, so the delivery of oxygen to the tis-
sues is impaired (Darling and Roughton, 1942). 
Sodium Nitrite and Brain Sensitivity 
Baumel et al., (1971) have reported evidence that 
pretreatment of animals with sodium nitrite enhances the 
depression of brain neurons. The evidence can be summar-
ized as follows; sodium nitrite pretreatment: 
l. at 22°C ambient temperature, markedly increased the 
duration of' narcosis due to barbital or hexobarbital, 
shortened the onset of narcosis due to barbital and 
produced hypothermia in mice. However, at J0°C 
ambient temperat u re tht! hypothermic efi'ect was abol-
ished as was the i ncrease in duration narcosis due to 
barbital. 
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2. significantly lowered the hexobarbital whole-body levels 
in mice at awakening. 
J. protected mice against intracerebral semicarbazide in-
duced convulsions. 
4. induced potentiation of barbiturate narcosis was pre-
vented by hypcrbaric oxygen ( OHP), a trea-r;ment kn.own 
to reduce brain levels of GABA (Wood, .£.E_ al., 1963). 
Sodium nitrite reduced absorption of' barblta1-c14 from 
the site of injection but did not alter its penetration in-
to brain. 
Desioramine 
Like many drugs, desipramine (DMI) and its parent 
substance imipramine, interact with other compounds in a 
complex manner. These two tricyclic anti-depressants en-
hance the action of amphetamine (Carlton, 1961) and tremo-
rine (Sjoquist and Gillette, 1965); they potentiate hypo-
thermia due to infusion of NE, epinephrine or isoprenaline 
(Jori and Garrattini, 1965) and imipramine prevents or 
cow~teracts hypothermia induced by ~eserpine (Garrattini 
and Jori, 1967). 
DMI and Brain Sensitivity 
Shah and Lal (1971) have presented evidence that 
pretreatment of mice with DMI lower5 neuronal excitability. 
The evidence can be summarized as :follows; rn-II pretreatment: 
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1. at 2J°C ambient temperature, significantl·y poten"tiated 
narcosis due to barbital or hexobarbital, shortened 
the onset of narcosis due to barbital and produced a 
significant reduction in body temperature. However, at 
30°c ambient temperature the hypothermic ef1'ect was 
abolished as was the potentiation of barbital-induced 
narcosis. 
2. significantly lowered the hexobarbital whole-body levels 
at awakening. 
3. did not alter rate of penetration of barbital into 
brain. 
SOCIAL DEPRIVATION 
Depriving an organism of social interactions removes 
the normal stimuli obtained from group contacts and results 
in changes in the behavior and physiologic responses of the 
organism. 
Prolonged social deprivation has been observed to 
elicit intense aggression in male mice (Yen~ al., 1959). 
These animals possess a heightened neuroexcitability which 
manifests itself in i1yperreactivity to physical stimuli 
(Kimbrell, 1967; King et al., 1955). 
Physiologic alterations in socially deprived ani-
mals include a smaller adrenal weight (Valzelli and 
Garrattini, 1968), higher plasma corticosterone (S :~ gg, 
1969), decreased body weight (Hatch et al., 1965) and de-
creased turnover of brain serotonin (Giacalone et al., 1968) . 
The levels of' brain GABA in the dog have also been corre-
lated with social deprivation (Agrawal et al., l967) . 
Social Deprivation and Brain Sensitivity 
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Baumel et al. (1970) have presented evidence that 
prolonged social deprivation of' mice raised arousal levels 
such that their susceptibility to CNS depressants was re-
duced. The evidence can be summarized as follows; social 
deprivation of' mice f'or 5 weeks: 
1. significantly reduced duration of' narcosis due to 
barbital, pentobarbital or hexobarbital but did not 
alter onset of' barbital-induced narcosis, suggesting 
that the permeability of' drugs into the CNS was not 
changed. 
2. ~ignificantly increased hexobarbital whole-body levels 
at awakening. 
DRUG WITHDRAWAL 
Barbiturate 
The chronic administration of' barbiturates has been 
reported i;o produce tolerance and phys i cal dependE•r:.ce in 
humans (Isbell 1 1950) and in common laboratory animals 
(Crossland and Lecnard, 1963; Essig, 1966; Norton, 1970; 
Jaffe and Sharpless, 1965). 
Abrupt disconti.nuation of' barbiturates, subseql.<ent 
to its chronic administration in large doses, resulted in 
spontaneous tonic-clonic convulsions in rats (Essig, 1966). 
The abstinence convulsions, a reliable index of the barbi-
turate abstinence syndrome, have been reproduced in several 
animal species ( Es sig, 1967). Wahlstrom (1971) reported 
that chronic barbital administration and withdra·Kal in-
creased the hexobarbital thresholds ("the quantity of 
intravenously infused hexobarbital needed to produce a 
burst suppression of 1 second or more in the EEG") in rats 
by more than 45% as compared to a pre-experimental average. 
Since the aforementioned thresholds were not influenced by 
an increase in metabolism (Wahlstrom, 1968), the data sug-
gest that an alt9ration in neuronal sensitivity to barbi-
turates had taken place. 
Since levels of brain GABA have been COITelated with 
convulsions under a variety of conditions (Essig, 1968) , 
suggested that the convulsions induced by barbiturate with-
drawal could be due to reduction in brain leveJ.s of GABA. 
This was furt~er supported by the fact that amino-oxyacetic 
acid (AOAA), a compom1d known to elevate brain GABA 
(Wallach, ~961), protected rats and dogs against barbiturate 
withdrawal induced convulsions (Essig, 1968). 
Alcohol (Ethanol) 
Chronic administration of alcohol has be en reported 
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to produce tolerance and phy~ical dependence in humans 
(Isbell et al., 1955) and in common laborat ory animals 
(Goldstein and Pal, 1971; Freund, 1969; Essig and Lam, 1968). 
Abrupt alcohol withdrawal after chronic administ:ra-
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tion has b::?en shown to result in a typical abstinence syn-
drome, which is characterized by tremors, generalized 
tonic-clonic convulsions and a lowering of the threshold for 
electroconvulsive seizures (Freund, 1969; Essig and Lam, 
1968; McQuarrie and Fingl, 1958). Freund and Walker (1971) 
found that C57BL/6J mice, a strain genetically resistant to 
the induction of audiogenic seizures, could become highly 
susce9tible to audiogenic seizures upon abrupt withdrawal of 
ethanol after its chronic administration. Several hypotheses 
have been proposed to explain the mechanism of convulsions 
occurring during withdrawal from addictive drugs (Mendelson, 
1970). 
Animal models for alcohol dependence have only very 
recently been developed. Essig and Lam (1968), Ellis and 
Pick {1969) and Freund {1969) have shown that development 
of physical dependence in animals is a surpri~ingly rapid 
process, as compared with the slow progress of alcoholism 
in man. The shortest reported times :for producing withdraw-
al reactions are about 2 weeks in dogs and monkeys and I+ 
days in mice. The recent report by Goldstein and Pal ( 1971) 
indicqte that, it is possible to produce alcohol dependence 
in mice by maintaining intoxicating blood levels o~ ethanol 
for two days. They used pyrazole, an in11.ibi tor of alcohol 
elimination in vivq_, and housed animals in an atmospher e of 
ethanol vapour. 
The assumed role of GABA as an inhibitory transmitter 
has elicited interest in possible effects of ethanol on 
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levels and metabolisr.1 ot~ GABA. Ethanol has been repor-ced to 
raise the concentration of GABA, glutamate and aspartate, 
and to decrease glutamine, in the brains of rats in vivo 
---
(Hakkinen ans Kulonen, 1961) and electrically stimula~n d 
cerebral cortex tissue in vitro (Hakkinen et al., 1963). An 
acute intoxicating dose of ethanol, to rats, has been re-
ported to decrease the concentration of' GABA in cerebral 
hemispheres and in cerebellum (Gorden, 1967). In the brains 
of rats given 15% alcohol as sole fluid for 23 days, bol.LLd 
GABA was slightly lowered whereas free GABA was not changed 
(Hagen, 1967). 
Alcohol and Pvrazole 
Pyrazole inhibits the metabolism of ethan.::>l both in 
vitro and in vivo. In 1963, Theorell and Yonetani reported 
that pyrazole inhibited liver alcohol dehydrogenase by 
formation of a ternary com;>lex with ADH and nicotinamide-
adenine dinucleotide (NAD). Lester .et a l. (1968) and 
Goldberg and Rydberg (1969) showed that pyrazole inhibited 
ethanol metabolism in rats as evidenced by the persistence 
of high blood alcohol concentrations. In the former si::udy, 
it was reported that pyrazole and li·-subs tituted pyrazoles 
inhibited ethanol metabolism, while substitution in any 
other position did not produce a similar inhibition. More 
recently, two investigations (Bustos et al., 1970; Morgan 
and DiLuzio, 1970) appeared which dealt with the induction 
of fatty livers in animals treated with pyrazole-ethanol. 
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Although the principal findings of these studies were dis-
tinctly controversial, the investigators were in agreement 
with regard to one important observation: the concentrations 
of blood ethanol in rats treated with pyrazole-ethanol per-
sisted at a high level for as long as 16-20 hr, thus indi-
cating a pyrazole-induced inhibition of ethanol metabolism. 
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EXPERIMENTAL 
Animals: 
Swiss albino, random bred male mice weighing 25-35 g 
and Sprague-Dawley albino, rando'm bred male rats (Charles 
River Farms, Wilmington, Mass.) weighing 150-200 g were 
used. They were housed in animal quarters maintained at 
21-2J°C with room lights alternated on a 12h light-dark 
cycle. Food and water were available ad libitum up to one 
hour before each experiment. Animals were used not earlier 
than one week after receipt from the supplier. 
Materials: 
Analytical reagent grade chemicals or equivalent 
were used throughout the study. Co-factors were purchased 
from P-L Biochemicals Inc., :MihV"aukee, Wisc. The drugs 
and the enzymes used in this investigation were obtained 
from their respective manufacturers. 
HyPobaric Chambers: 
The hypobaric chambers (Figure 2) utilized room air 
and consis~ed of four plexiglass desiccators (Internal di-
ameter 10'', height 14", Ace Glass Inc. ) connected j_n paral-
lel via 1/2" rubber tubing to a vacuum pump (1/2 h.p., 
) ,, Gelman Instruments through a manifold consisting 01' l/L~" 
copper pipe. The degree and rate of reduction in ambient 
pressure within the chambers was controlled by a cent.ral 
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needle valve attached to the air intake manifold. The baro-
metric pressure within the system was monitored by vacuum 
gauges on individual chambers and mercury manometer attached 
to the end chamber. Separate needle valves placed along the 
system permitted recompression of individual chambers inde-
pendent of the other units. 
Decreasing barometric pressure within the chambers to 
364 mm Hg (p02=76 nun Hg, equivalent to a 10% oxygen atmos-
phere at sea level) resulted in room air entering the sys-
tem at approximately 9 liters/min which ~as assumed to be 
adequate for continuous removal of expired carbon dioxide, 
and prevention of excess moisture condensation within the 
chambers. Under these conditions, the temperature within 
the chambers was maintained within 1° of the ambient tern-
perature. 
Exposure to Hypoxia: 
The animals were placed, in pairs, in each of the four 
chambers which were then decompressed in a 10 minute period 
to 364 mm Hg (p02=76 mm Hg, equivalent to a 10% oxygen at-
mosphere at sea level). Control mice were run concurrently 
in identical chambers open to room air. One group of mice 
was exposed continually to hypobaric hypoxia for JO minutes 
and the other group was exposed for 60 minutes. The animals 
were then removed from the hypoxia chambers at the end o f JO 
or 60 minutes and were immediat ely frozen in liquid nitro g en. 
The experiment s were done at 22 and J0 °C ambient tempe r ature 
in a constant temperature environmental chamber. 
Brai n Lesioning : 
Bilateral electrolytic lesions were produc e d in 
175-200 g male albino rats of the Sprague-Dawley stra in , by 
means of David Kopf stereotaxic apparatus. The method wa s 
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that of Zuromski ~al. (1972). The subjects ·...-ere anaesthe-
tized with Nembutal (40 mg/kg) supplemented by local appli-
cation of Xylocaine. Bilateral septa! lesions were produc e d 
using 2 ma anodal current for 20 sec through the llllinsulated 
tip of a stainless-steel pin. The stereotaxic j_nstrument 
with a modified head-holder which held the head level was 
used to position the electrode, 1.0 mm anterior to bregrna, 
2.5 mm lateral from r,he midline, _5.5 nm1 deep (:from t11e sP ..r-
face of the cortex), and 25° tow-ard. the midline. Sham-
operated controls and normal cont rols were also included. 
In the sham-operation the animal was anaesthe tiz e d, placed 
in the stereotaxic apparatus and t he skull dril led but dura 
spared. All animals were given 25,000 units of procaine 
penicillin post-operatively. All animals were housed indi-
vidually immediately after the operation and then housed 
two per cage on the seventh postoperative day u...~til termi-
nation of the experiment. Barbital induced narcosis was 
measured in order to confirm location of the septa! lesions 
(see Harvey et al. 1964). 
Measurement of Drug-Induced ~rcosis: 
Duration of narcosis was taken as the interval be-
tween the loss and the regain of righting reflex, the end 
point of which was determined according to Wenzel and Lal 
(1959) using two rightings wi t hin JO s e conds. The interv a l 
between injection of the drug and loss of' rightin g r e fl e x 
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was designat ed as onset of narcosis (induct ion time). Ba r bi -
tal was injected intraperitoneally as the sodium salt in 
distilled water. Determination of duration of barbi t al na.r-
cosis and induction time were done as described above. 
Social Deprivation: 
Mice weighing 18-20 gm were housed either l to a cage 
or 10 to a cage in stainless steel cages (9.5 11 x 7" x 711 ) 
with wire mesh on fronts and bottoms. Solid walls on the 
remaining 3 sides reduced visual or tactile contacts of the 
isolated mice with other animals. Animals were not handled 
or removed from their cages during the deprivation period 
but were kept clean by changing the bottom pans regularly. 
The mice ·were subject to all daily noises of the animal 
room. Ambient temperature was maintained at 21-2J°C and 
room lights alternated on a 12h light-dark cycle. 
Chronic Phe nob arbit a l Administration and Withdra wal: 
The fluid intake of mice was restricted to increa s-
ing concentrations of phenobarbital in drinking water. 
Their initi a l dose was 50 mg/kg/day and was increased week-
ly until they received 400 mg/kg/day. Phenobarbital solu-
tion also contained 0.2 mg/ml saccharin to mask the bitt e r 
taste of the barbiturate. Control animals received 0. 2 
mg/ml of s ac charin in drinking water :for four weeks. 'Thi s 
method was orig i n ally r eported by Crossland and Leonard 
(196 3 ). 
Durin g t ha exp e rirne:it six mice were hous ed per c age. 
Fresh phenobarb i t al so l ut i on (100 ml) was g i v en e v ery d ay 
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and total amount of' the solution consumed by a group of six 
animals per day was recorded during the entire period of 
four weeks. 
At the end of four ·weeks of phenobarbital, the drug 
administration was discontinued. The animals were given 
drinking water only. After 24 hours, eight randomly se-
lected experimental animals were exposed to an auditory 
stimulus (100 dB for JO seconds). Mice showing convulsions 
within JO seconds were immediately frozen in liquid nitrogen 
and were stored at -40°C. The same procedure w~s followed 
for 48 and 120 hour withdra1n1 animals except that, some of 
the 48 hour and all of the 120 hour withdrawn animals did 
not exhibit any CNS hyperexcitability (convulsions). Fur-
ther, a group o!~ 24 hour wi thctrawn 2,nimal:: we.•.:=; sacri:':Lced 
without any prior exposure to the auditory stimulus. Con-
trol animals were exposed to the stimulus for JO seconds 
before sac~ifice. 
Ethanol Vapour-Chamber: 
The ethanol vapour-chamber (Figure J) consisted of' 
a flat bottom, cylindrical glass jar placed horizontally 
on a wooden platform. It contained a perforated floor, 
drinking water and food pellets . The open end of the jar 
was clo s ed by a wooden frame with a circular window (5" di-
ameter) for the introduction of the animals and was fitted 
with a rubber stopper (2" diameter) having four holes. The 
rubber stopper was fitted with t·Ko inlets (one for air a::ld 
the other one foy ethanol) and outlet tubing5 and a thermom-
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et er . Air and alcohol inflows w~re regulated by t;rn separa-:;~ 
flow meters (Hoke Inc., Cresskill, N.J.). 
Determination of Ethanol Vapour-Concentration : 
The enzymatic method o .f Lundq<Ji.st (1959) was used f0r 
the determination . A sample of chamber air , l ml , ;..•a s with-
drawn in Hamilton air-tight syringe (Hamilton Company Inc. , 
Cal.). The air sample was then injected througr ... the e.i r -
tight rubber cork into the head spa~e of a vial containing 
5 1 ( J, R 1 b ff C 1 1 0 1 rn, N.AD· ·) "~ •n° m . .,. • u m u er + • m_ enzyrne + ~ . _,_ _. . ~ - ~ ... :... 
reaction mixture used for the determination of e~h~nol in 
blood. The reaction was allowed to proceed for 60 min at 
room temperature and the absorption was measured at J40 rau . 
The optical cl ·::.' . .: i ty, after subtraction of a blaP..k value (1 
ml O f' . ro on· -· -:1' ·, ·-a ·· 
- ' <:> • .;... J ' .~ . :::> used in t he following formula to get 
mg of e thanol/liter of chamber air. 
Sample OD X 39 _ . s~andard 0Dl2mg/ml) ·2-mg ethanol/liter of chamber 
air 
The standard analysis was made by a dditicn of 100 ul 
of the ethanol standard soluti on containing 1, 1.5 and 2 mg 
of ethanol per ml of distill~d water . Figure 4 demonstrates 
the relationship be~ween air flow (liters/oinute) and cham-
ber air-ethanol concentration (mg/liter) • 
.....--/ 
Df~terminat io r. of Blood EthC!-_nol - level~ : 
The assay ::_)·rocedure was that of Lundquist (1 959) . 
Mice ·we re removed from the chamber and \·.r ere sacrificed by 
cervical dislocation. Ab~ut 150 ul blood 1>'a s withdrawi:1 :from 
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Figure 4. RELATIONSHIP BETWEEN AIR-FLOW (liters/min) AND 
CHAMBER AIR-ETHANOL CONCENTRATION (mg/liter). An air-
ethanol mixture was obtained by mixing two streams of air: 
one directly to the chamber at a rate of 2.5, 5 or 10 
liters/min and the other bubbling through absolute ethanol. 
(Reagent Quality, u.s.P.) contained in a glass jar to the 
chamber at a flow rate of 0.75 liters/min (which was kept 
constant). Each point represents the mean + S.E. of 
three determinations. 
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the heart with a tuberculin syringe. The sample containing 
100 ul of blood was then deprotenized by means of perchloric 
acid (4 volume, 3.4%). The supernatant obtained after cen-
trifugation at 2500 rpm for 10 min was used directly for 
analysis. The supernatant (100 ' 11) was added to l~ .8 ml of 
a buffer containing pyI:ophosphat~ and .semicarbzide1 at pH 
8.6-8.7, together with lOOul of 1.3% NAD2 so.l.ution. The 
enzymatic reaction was started by addition of 50 ul of 
crystalli.ne yeast alcohol deh.ydrogenase suspension. 3 Tne 
reaction was allowed to proceed for 60 min at room tempera-
ture and the a.bsorption '~as measured at 340 mu. The optical 
density, after subtraction of a non-e thanol blank valw-) , 
was proportior.al to the concentration of ethyl alcohol 5_n 
blood. The standard analysis was made by addition of 100 
ul of absolute ethanol standard solution containing l, 1.5, 
2 and 2. 5 mg of ethanol per ml of' d.istilled water. Fig·ure 
5 demonstrates the standard curve for quantitative deter-
mination of' ethanol by the enzymatic method of Lundquist 
(1959). 
1 Prepared by dissolving 10 g of' sodiuJn pyrop:10sphate, 2.5 g 
of semicarbazide hydrochloride, 0.5 g of' g l ycine and 10 ml 
of 2N NaOH in sufficient water. The final volume was ad-
justed to JOO ml with distilled water and 'the pH was a d-
justed to 8.6-8.7. 
2Nicotinaruide-adenine dinucleotide. 
330 mg of' +.he enzyme '-ms suspended in 1 ml o:f saturated 
solution of ammonium sulfate. 
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Figl,lre 5. STANDARD CURVE FOR QUA.i~TITATIVE DETER.i"IINATION 
OF ETHANOL IN BLOOD. The enzymatic method of Lundquist 
(1959) was used. Pure yeast alcohol dehydrogenase (JO 
mg/ml), 0.05 ml, and l.J% NAD (0.1 ml) ~as added to the 
e~h~nol solution containing semicarbazide -glycine buffer, 
P.If..: 896-8.7. After 60 minutes at room temperature the 
mixtures were read at J40 mu. 
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Chronic Ethanol Intoxication and Withdrawal: 
The animals were exposed con'tjnually for 96 hours in 
the ethanol vapour-chamber (Figure J) to an . air-ethanol mix-
ture obtained by mixing two streams of air: One directly to 
the chamber at a rate of 5 liters/minute and the other bub-
bling through absolute ethyl a]_cohol (u. S. P.) c vntained in 
a glass jar to the chamber at a flow rate of· O. 75 liters/ 
minute. With the10e flow rat 1as the chamber air-e'thanol con-
centration re~ained at 10 mg/li~er (Fig~re 4). The mice 
were removed from the chamber twice a d ay :f~r about 25 m=.:.n-
utes in order to weigh them and to inject pyrazole (once 
daily). Pyrazole ;..·as given to obtain stable blood ethanol 
levels; it has been shown to icl1ibit the metabolism of 
ethanol both in vitro and in vivo (Theorell et al., 1969). 
The dose of pyrazole we used was, O • .5mrno .le/kg ( Jli· mg/kg), 
i.p., given at O, 24, 48 , and 78 hours during the exposure 
of mice to an air e'thanol mix'ture. 
The chamber air-e'thanol concentration (10 mg/li'te:r) , 
and the daily dose of pyrazole (0.5 mmole/kg) mainta14ed 
the blood alcohol-levels of mice at 1.5 to 1.9 mg/ml for 
four days (Figure 6) . 
The mice were removed from the ethanol vapour-cham-
ber 24 hours after their last dose (at 72 hours) of pyrazole. 
They were then ob=erved almost continually for 12 hours, 
with scores of abstinence synd.rome recorded hourly. 
Measurement of Gamma-A.minobutyric Acid : 
The assay procedure ·Kas that o:f Graham and Aprison 
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Figure 6. BLOOD ETHANOL CONCENTRATIONS DURING EXPOSURE 
TO ETHA1 0L VAPOUR. Each point repres e nts tha average 
blood ethanol-levels of two mice. The y were exposed to 
ethanol vapour concentration of 10 mg/liter for 96 hours. 
Pyrazole (0.5 mmole/kg) was injected at O, 24, 48 and 72 
hours. Blood samples were taken for ethanol assay each 
afternoon be1~ore pyrazole was inject ed. f indicate with-
drawal (removal of the animals from the chamber) • .,_ ___ __ 
blood ethanol-levels dropped to 0.24 mg/ml in about 5 
hours after withdrawal. 
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(1966). Whole mouse or rat heads were f'rozen in liquid n.i-
trogen and kept at -4o 0 c for 20-24 hours. At the time of 
assay whole brains were rapidly removed (within 45 seconds), 
weighed and homogenized: a) a mouse brain in 20 volumes of 
ice-cold 75% (v/v) ethanol or b) a rat brc.in irL ~ volumes 
of ice-cold 75% ethanol. Samples were then centrifuged at 
5000 rpm at 0°C for 15 minutes. The superuates were re-
moved and stored at 4°C while the pellet was resuspended in 
20 voltune (for a mouse brain) or 4 volume (for a rat brain) 
of ice-cold 75% ethanol and centrifuged as above. Both 
supernate fractions were then combined and mixed tl1oroughly. 
Two ml samples (from a mouse brain superna~e) or o .4 ml 
samples (from a rat brain supernat.:i) were added to sample 
vials and evaporated to dryness at 60°C in a >·rater bath with 
constant air flow into each vial. Samples were kept at 
-4o~c for 24 hours at which time G.ABA was measured. The 
contents of each vial were suspended in 5 ml of 117ate-r. ~~.vo 
ml of sample was shaken with an equal volume of chlo~of'or.:n 
and centrifuged in a clinical centrifuge (Interna.T;iona.i 
Equipment Company) at 3500 rpm for 20 minutes. 
The substrate solution cCJnt:ained 1.4 ml pyrophosphc-:_i:;e 
1 ? buffer (0.1 M, pH 8.4), 0.2 ml NADP- (0. 005 M in water), 
1 Prepared by dissolving 4.46 g _~a?P?O -lOH 0 in 80 :n.:L water. 
Norit-A was added and the sollnion-sfirrea for 15 min a .fr.er 
which the solution was filtered through Celite . The pH was 
adjusted to 8.4 with lN HCL and -the -..olume a.djusted to 100 
ml. The buffer Ka s stored in an amber bottle a;; !.i.°C ali.G 
was prepared fresh 24 hour prior t o each assay. 
2Nicotinamide-adenine dinucleotide phosphate. 
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O. 2 ml alpha-keotglutaric acid ( O. l M in bu1~fer), 0. 2 ml 
mercaptoethanol (0.06 M in buffer) and 10 mg GABase enzyme. 
Incubation mixtures contained O.l ml b r ain sample, standa rd 
or water; O.l ml pyrophosphate buffer and 0.04 ml substrate 
solution. Tissue blanks were prepared in the same ma nner 
except that no GABase was added. Incubations were for 45 
min at J7°C in a Dubnoff metabolic shaker. After incubation, 
0.2 ml alkaline phosphate1 was added to the tubes and mixed 
thoroughly. Tubes were heated at 60°C for 15 min, then 
0.2 ml Na0H-H2o2
2 
was added, mixed thoroughly and the tubes 
were heated 60°C for 10 min. One ml of water was added to 
the tubes and the contents were mixed ~horoughly and the 
fluorescence read immediately in an Aminco-Bowman spectro-
photofluorometer (excitation at 360 mu ar.d emission at 460 
mu, sensitivity setting at 50 and slit width of 1/64 in). 
Values were reported as umoles GABA/g brain (wet weight). 
Measurement of Glutamic Acid Decarboxv lase Activi_!.Y:: 
The assay procedure was that of Roberts and Simonsen 
(1963). The C-14-L-glutamic acid substrate solution was 
made by combining 1 ml of 1-C-14-L-glutamic acid (25 micro 
Ci), 25 ml of 0.2M L-glutamic acid -adjusted to pH 6.5 wi th 
KOH, 10 ml of 5 per cent (v/v) Triton X-100, J6 ml of o. 4M 
1 Prepared by dissolving 15.2 g NaJPo4 -12H20 and 2.6~ g Na2HP01 in sufficient water to ma ke 100 ml. Solution 
stored.:+in amber bottle at room temperature. 
2~repared fresh just prior to use by adding 0.2 ml 3% 
H2o 2 to 10 ml of lON NaOH. 
was 
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potassium phosphate buffer1 (pH 6 .5) antl 5 mg pyridoxal 
phosphate. This solution was adjusted to a final volume of 
100 ml with 0.2M potassium phosphate buffer2 (pH 6.5). The 
solution was 5 x l0- 2M in l-C-14 glutamate (sp. act. 1.25 
uc/umole), 2 x l0- 4M in pyridoxal phosphate, 0.5 per cent 
in Triton X-100 and 0. 2M in phosphate. The final pH was 
6.5 and the mixture was stored in 25 ml portions at -40°C 
until use. 
The procedure for collection of brain samples was as 
described in the GABA-T assay except that brains ,.;ere horn-
ogenized in 7 vol of ice-cold deionized water. One ml of 
homogenate was added to a scintillation vial that was used 
as an incubation flask and one ml of Hyamine lO-X was added 
to another vial. The unit3 ,,·as assembled and the homogenates 
were preincubated at J7°C for 10 min during which time each 
flask was flushed with 100 per cent nitrogen for 2 min. The 
reaction was started by the addition of one ml of subsc;ra:te 
l Prepared by adding 0.4 dibasic potassium phosphate to 0.4 
M monobasic potassium phosphate until pH 6.5 was reached. 
2 Prepared by adding 0.2 M dibasic potassium phosphate to 
0.2 M monobasic potassium phosphate until a pH of 6.5 was 
reached. 
3The unit consisted of 2 counting vials connected by a glass 
U tube (l/4 in I. D.). The vials and U tube were connected 
by means of 1/2 in lengths of high pressure tubing (soft 
rubber -- l/4 in I.D., 5/8 in O.D.). Two needles (23 
gauge, l in) per u,.~it ~ere inserted through the tubing and 
removed after addition of C-14 sub s trate. Sulfuric acid 
was introduced through the t ubing by means of a needle and 
syringe at the end o f the incubation period. During pre-
incubation and after nitrogen flush, needles were stoppere d 
with 1/8 in O.D. glass tubing sealed at both ends. 
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solution (warmed to 37°c) by means of a hypodermic syringe . 
The needles were immediately removed to seal the unit and 
the samples were incubated at J7°C in a Dubnoff metabolic 
shaker. 
At the end of exactly 15 mi n, 0.2 cc of 4N sulfuric 
acid was added to stop the reaction. The uni ts ,.;ere allo·wed 
to shake for another 60 min to insure complete absorption 
of the C-14-0 by Hyamine (10-X). The counting vial was 
2 
detached and 10 ml of scintillation solution1 was added. 
Radioactivity was counted in a Packard Tri -Carb liquid 
scintillation 5pectrometer (25 per cent gain setting). In-
ternal standards of C-14 toluene (New England Nuclear) were 
added to every other sample for determination of per cent 
.. 
efficiency. All samples were counted for 10 min. Values 
were reported as urnoles co2 /gm brain/hr. 
Measurement of GaITlffia-Aminobut ·vric Acid Transaminase Ac ti Yi ty 
The GABA-T assay procedure was that of Salvador and 
Albers (1959). Brains were removed rapidly with the aid 
of other investigators, weighed and homogenized in three 
vol· ice-cold 1.25 per cent Triton X-100. Five ml of' GABA-
2 
alpha-KG mixture '"as a.djed to o. 2 ml of homog13nate.. One-
1 
Prepared by dissolving 1 g POPOP (1,4-bis 2·-(5-phenyl -
oxazolyl) benzene) and O.l g PPO \s,5 diphenyloxazole) 
in sufficient toluene to make l liter. 
2 Prepared by dissol ·ing 2.575 €GABA 1nd 1.46 g -KG ir. 50 
ml water. The pH wa~ brought t o 8 .4 with 5N· NaOH and the -
volume adjusted to 100 ml with water. This mixture was 
prepared fresh daily and was 0.25M GABA and O.lM ir. -KG. 
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half ml samples of this mixture were added to 0.5 ml of DAB 
reagent1 ( Salganicoff and DeRobertis, _1965) and stored on 
ice for use as tissue blanks. The removal of brains, 
weighing and homogenization proced-ures took no longer than 
45 min. for 20 mice. 
The succinic semialdehyde standard was prepared ac--
cording to Prescott and Waelsch ( l'.)46). T"'·enty mg n.inhydrin 
was mixed with 1.4 ml glutamic acid solution (0.001 g/ml in 
0.5N acetic acid) after which time 2 . 6 ml. of 0.5N acetic 
acid was added. Reagent blanks contained 4 ml of 0.5N 
acetic acid and 20 mg ninhydrin. Reagent blanks and stand-
ards were placed in boiling water f'or 10 min . Af-t er the 
tubes were cooled in ice, the f~ollowing reagents were added 
at 5 min intervals: o.4 ml guanidine carboca~e (14 per cent 
in water), 1 ml lead acetate (12 per csnt in wat er prepared 
fresh each day), 0.5 ml of 5N NaOH a.nd 0.1 ml water. Tubes 
were centrifuged at J,000 rpm for 10 min in a clinical 
centrifuge. After centrifnr;a i:;.i.on , O. 5 ml aliquots of -:·e·· 
agent blank and star.~dard were added to o. 5 ml of DAB re-
agent, mixed and stored on ice. 
The GABA-~-KG mixture containing brain homogenate 
was incubated in a Dubnoff' metabolic shaker under room air 
at J7°C for 60 min. Arter incubation, 0 .5 ml aliquots 
were added to 0.5 ml DAB reagent. 
1 ~repared by dissolving 2.8 g J.5 diaminobensoic acid HCl 
in 25 ml lM potassiwn phosphate buffar (pH 5.9) (1 vol of 
lM K2HoP4 plus 9 vol of HI KH2 PO ) • The pH --;.;as broug~1t to 5.9 with 5N NaOH and adjusted to a final volume o f 50 ml 
with phosphate buffer . 
Samples, tissue blanks, reagent blanks and standards 
were heated at 6o 0 c for 60 min. Nine ml water was added to 
each tube and tubes were centrifuged at J,000 rpm for 10 
min. Forty ul of supernatant was mixed with 10 ml water and 
samples were read in an Aminco-Bowman spectrophotofluorometer 
(excitation 405 mu, emission 505 mu, sensitivity setting 
at 50 and slit width of 1/64 in). Values were reported as 
umoles succinic semialdehyde/gm brain/hr. 
Determination of Brain Protein 
The assay method was that of Lowry et al. (1951). 
Brains were removed rapidly, weighed and homogenized in 9 
vol of isotonic (1.15%) KCl. A o.4 ml aliquot of the super-
nate, obtained after centrifugation of the whole homogenate 
at 10,000 rpm for 20 min, was added to l.6 ml of 0.5N NaOH. 
The test tubes were then placed in a boiling water bath to 
hasten dissolution. Following one hour in the water bath, 
a 0.2 ml of the diluted sample was added to 1 ml of 0.5N 
NaOH. To this was added 5 ml of reagent A1 and mixed for 
10 seconds. Twenty minutes subsequent to the last addition, 
0.5 ml of a commercial Folin-Phenol reagent (diluted to lN 
with distilled water) was mixed with the sample. The sample 
was allowed to stand at a room tempera t ure for 40 minutes. 
The intensity of the blue color was read at 500 mu. A blank 
prepared using 1.15% KCl and was treated as the other samples. 
Bovine serum albumin was used as a standard. 
l Reagent A: 1.0 ml of 1% aqueous Cuso4 , 1.0 ml of 2.7% 
aqueous potassium tartrate added to 100 ml of 2% aqueous 
Na2co3 • 
Statistical 1ethods: 
The student "t" test f'or independent means, Chi-
square 2 x 2 contingency analysis (Dixon and Massey, 1969) 
were used to test f'or dif'f'erences between control and ex-
perimental groups. Correlation coefficients were calcu-
lated using linear regression analysis (Dixon and Massey, 
1969). The results were also analyzed by the analysis of' 
variance using a mixed-ef'f'ects model (Dixon and Massey, 
1969). 
Tests were performed on an Olivetti Underwood 
Programma 101 desk computer and IB:H computer J60/50. The 
exact level of' significance was determined f'rom the re-
spective standard tables. 
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RESULTS 
In order to determine the relationship bet·ween al-
teration in CNS sensitivity to barbitura~es and changes in 
brain GABA levels we altered the CNS sensitivity of' the: 
animals to barbiturates by utilizing the following lrJlown 
conditions: 
A) exposure to hypobaric hypoxia 
B) septal lesions 
C) treatment with drugs, desipramine (DMI), sodium 
nitrite or pargyline 
D) social deprivation 
E) abrupt withdrawal following chronic barbiturate or 
alcohol administration. 
The brain BABA-levels were determined after the 
above treatments. 
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A. ACUTE HYPOXIA 
Since acute hypobaric hypoxia, 364 mm Hg (p02=76 mm Hg) 
has been reported to alter the brain sensitivity of mice to 
barbiturates (Baurnel et al., 1970b), we used the similar hy-
poxic ~xposure in our study. Further, the magnitude of al-
teration in brain sensitivity differed at 22°C and at J0°C 
ambient temperature (Baurnel, 1970). Therefore, we measured 
brain gamma-aminobutyric acid at both 22°c and J0°C ambient 
temperature. 
1. Effect of Hvpoxia on BraL~ Gamma-aminobutyric Acid 
Table 1 summarizes the effect of acute exposure to 
hypobaric hypoxia (364 mm Hg, p02=76 mm Hg) on mouse brain 
GABA-levels. The brain GABA-levels were markedly elevated · 
under the hypobaric environment, during both JO and 60 min-
ute exposures. However, the magnitude of increase in brain 
GABA differed at 22°C and J0°C ambient temperature. The hy-
poxic exposure for JO or 60 minutes at 22°C ambient temper- · 
ature caused 49 and 54% increase in brain GABA-levels, while 
hypoxic exposure at J0°C ambient tempera ture produced only 
29 and 40% increase in brain GABA concentrations, respec-
tively. 
The analysis of variance summarized in Table 1 shows 
the effect o f' three factors, name ly, hypox ia, hypoxia dura-
tion, and ambient temperature , a nd their interactions on 
brain GABA- ~evels. It can be seen that only hypoxia had 
a significan t effect on brain GABA, while hypoxia duration 
and ambient t emperature had no s ignificant interaction wi t h 
TABLE 1 
EFFECT OF HYPOBARIC HYPOXIA ON MOUSE BRAIN LEVELS OF GAMMA-
AMINOBUTYRIC ACID AT TWO AMBIENT TEMPERATURES 
Hypoxia Ambient u.moles GABA/g brain % Duration Temp. mean + S.E. (N) 
.Change 
(min) ( oc) Control2 Hypoxic 1 
JO 22 2.18+0.02 (7) J.2J.±,0.19 a (7) 49 
JO 2.J6+0.22 (8) J.05+0.10 b (8) 29 
60 22 2.14.±,0.10 (8) 3.29.±,0.lOa (8) 54 
JO 2.25+0.12 (8) 3.16.±,0.12a ( 8) 40. 
Analysis of Variance 
Source df MS F p 
Hypoxia Duration (D) 1 0.0008 0.005 > 0.05 
Ambient Temp. (T) 1 0.0004 0.003 >0.05 
Hypoxia (H) 1 14.516 91.J70 < o. 001 
DxT 1 0.0004 0.003 >0.05 
DxH 1 0.1056 0.007 >0.05 
TxH 1 0.0150 0.001 >0.05 
DxTxH 1 0.3751 0.094 >0.05 
Error 22. 0.1585 
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1. 364 nun Hg, p02=76 mm Hg (equivalent to a 10% oxygen 
atmosphere at sea level). 
2. Controls were run concurrently in identical chambers 
open to room air. 
Control vs. hypobaric; 
a p(0.001 
b p<0.01 
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the effect of hypoxia on brain GABA. 
B. SEPTAL LESIONS 
Heller et al. (1960) found that lesions in the septal 
area in rats caused a J-fold increase in barbital-induced 
narcosis, as compared with normal controls. This effect was 
found to be specific to the septal region (see Harvey~ aJ . • , 
1964). Considering this, we measured barbital induced nar-
cosis in septal rats at first, to make sure that the lesions 
were in the septal area, and then de~ermined the brain 
levels of GABA. 
1. Effect of Septal Lesions on Barbital Induced - Narco s is 
and Brain Gamma-a.minobutyric Acid 
The testing of septal rats with barbital was done on 
the 25th postoperative dayft The results are summarized in 
Table 2 . Bilateral lesions of the septal area produced 
marked increase in barbital induced-narcosis and decrease 
in onset of' narcosis. The brain levels of' GABA in the same 
septal rats were determined on the J5th postoperative da)·. 
Duty summarized in Table 2 show that there -.es no signifi-
cant difference in the levels of brain GABA between the 
septal rats and sham-oparated or normal control rats. 
C. DRUG TREATMENTS 
One hour pretreatment with DMI (Shah and Lal, 1971) 
or half hour pretreatment ,,-i th sodimn nitrite (Baumel e t al., 
1971) have been reported to alter the neuronal sensitivity 
TABLE 2 
EFFECT OF SEPTAL LESIONS ON BARBITAL NARCOSIS AND BRAIN LEVELS 
Experimental 
Groups 
Normal Controls 
Sham Operated2 
Septa1 3 
OF GAMMA-AMINOBUTYRIC .A:CID IN RATS 
I 
Barbita11 Narcosis 
Min. ± S.E. (N) 
Onset Duration 
76.0± 8.1 (6) 98.1±12.J ( 6) 
77.8±10.6a (6) 1Jl.8±19.7a (6) 
Jl.5± 7.1b (6) J21.6±J6.7b (6) 
1. 160 mg/kg injected intraperitoneally. 
2. Rats with drilled skulls, but intact dura. 
umoles GABA4/g brain 
Mean ± S.E. (N) 
2.JJ±0.08 ( 8) 
2.4o+o.o8a (8) 
2.5J+0.10c (7) 
J. Rats with bilateral stereotoxically placed electrolytic lesions in the 
septal area of the basal telencephalon. 
4. Rat heads were frozen in liquid nitrogen prior to the measurement of GABA 
in the brain. 
Normal controls vs. Sham-operated. 
ap < o. 05 
Normal con~rols or sham-operated vs. Septal. 
bp ( o. 001 
cp >0•05 
V1 
f-' 
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to barbiturates, at 22°C but not at J0°C ambient temperature. 
Pargyline, unlike DMI or sodium nitrite, altered the CNS 
sensitivity of our animals to barbital at both 22°C and at 
30°C ambient temperature (Table 6 ). Therefore, we measured 
brain levels of GABA in mice after DMI, sodium nitrite or 
pargyline (100 mg/kg, two hours) pretreatment at both 22°C 
and at J0°C ambient temperature, utilizing the same dosage 
and the same pretreatment time as reported by the afore-
mentioned workers. 
l. Effect 01~ Desipramine (rnn) on Brain Gamma-aminobutyric 
Acid and Body Temp e ra t ure at Two Ambien t 'I'~mper2.!_:::._i~ 
Table J shows the effect of DMI, 50 mg/kg, i.p., on 
brain G .. A...BA-levels at two ambient temperatures, 22 ;)C and J0 °C. 
DMI pretreatment caused a significant elevation in brain 
GABA at 22°C ambient temperature. However, the increase in 
brain levels of GABA caused by DMI at 22°C was absent at 
the higher ambient temperature. 
The analysis of variance swmnarized in Table J s hows 
the ef1~ect of two factors, namely, ambient temperature and 
DMI, and their interaction on brain GABA-levels. It can be 
seen that both ambient temperature and DMI had a significant 
effect on brain GABA. Also, there was a significant inter-
action between ambient temperature and Dz.II for their effect 
on brain levels of GABA. These d a ta suggest that J0°C pre-
vented the increase in brain GABA caused by DMI at 22 ° C 
ambient temperature. Furthermore, J0°C by itself cauE.<ed re-
TABLE J 
EFFECT OF DESIPRAMINE ON BODY TEMPERATURE AND 
BRAIN LEVELS OF GANMA-AMINOBUTYRIC ACID 
AT TWO AMBIENT TEMPERATURES IN MICE 
Ambient Mean + S.E. (N) 
Temp. 2 ( oc) Control Treated 
Rectal temp. 
1 
( oc) 22 J8.l.±0.2 (7) J4.8.±0.Ja (7) 
JO J7.7.±0.2 (7) J7.5±0.2 b (7) 
umoles GABA/g 
brain 22 2.46+0.08 ( 6) J.J8+0.14a ( 6) 
JO 2.07±0.15 ( 7) 2.09±0.lJ b (7) 
Analysis of Variance 
Source df MS F p 
Ambient Temp. (T) 1 5.J94 J9.18 < o. 001 
DMI (D) 1 1.775 12.89 < o. 005 
TxD 1 1.666 12.10 < o. 005 
Error 24 0.1J9 
27 
1. Desipramine (50 mg/kg) injected intraperitoneally 1 
hour prior to freezing in liquid nitrogen. 
2. Distilled water (10 ml/kg) injected intraperitoneally 
1 hour prior to freezing. 
Control vs. Treated 
a p <0.005 
b p <0.05 
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TABLE 4 
EFFECT OF VARIOUS DOSES OF DESIPRAMINE ON MOUSE BRAIN LEVELS 
OF G.AMMA-AMINOBUTYRIC ACID AT 22°C AMBIENT TEMPERATURE 
DMI1 umoles GABA/g Brain % 
(mg/kg) mean± S.E. (N) Increase p 
None 2 2.46±0.08 (i) 
12.5 2.57±0.11 (6) 4 > 0.05 
25 2.97.±,0.lJ (6) 20 <. 0.01 
50 J.JS+o.14 (6) 37 < o. 005 
100 J.75±0.11 (6) 52 < o. 001 
1. Desipramine injected intraperitoneally 1 hour prior 
to freezing in liquid nitrogen. 
2. Distilled water (10 ml/kg) injected intraperitoneall y 
1 hour prior to freezing. 
J 
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Figure 7. EFFECT OF VARIOUS DOSES OF DESIPRAMINE ON MOUSE 
BRAIN LEVELS OF GAMMA-AMINOBUTYRIC ACID AT 22°c AMBIENT 
TEMPERATURE. Desipramine was administered 60 minutes prior 
to sacrifice. Each point represents the mean ± S.E. Seven 
animals were used for the control and six for each dose 
level. Open symbols denote significant (p<0.01) difference 
from controls. P value represents rejection of the hypothe-
sis that the correlation coefficient (r) equals zero. 
duction of brain GABA-levels in control animals as compared 
to the control animals exposed at 22°C ambient temperature. 
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Since DMI pretreatment, at 22°C but not at J0°C am-
bient temperature, caused a dose-dependent hypothermia (Shah 
and Lal, 1971) with an optimum at one hour, this time period 
was used to investigate the effect of various doses of DMI 
on brain GABA-levels. Actual means, standard errors, levels 
of significance and percent increase in brain GABA ai~e 
shown in Table 4. Figure 7 illustrates the dose-dependent 
effect of DMI on brain GABA-levels. Til.ere was a significant 
correlation (r = 0.85, p <. 0.005) between "the dose of DMI and 
elevation of brain GABA. 
The effect of DMI on rectal temperature of mice at 
two ambient temperatures, 22° and J0°C, is described in 
Table 4. At 22°C ambient temperature, DMI caused a sig-
nificant reduction in body temperature with an optimum at 
one hour. However, hypothermia caused by DMI at 22°C was 
absent at the higher ambient temperature. Similarly, ele-
vation in brain GABA caused by DMI at 22°C was absent at 
J0°C ambient te~perature. 
2. Effect of Sodium Nitrite on Brain Gamma-aminobutyric. 
Acid and Body Temperature at Two Ambient Tempera·tures 
Table 5 shows the e:ff'ect of sodium ni"trite, 100 mg/ 
kg, i.p., on brain GABA-levels at two ambient tempera-cures, 
22° and J0°C.At 22°C ambient temperature, sodiu.~ nitrite 
caused a significant elevation in brain GABA. However, the 
:I'ABLE 5 
..EFFECT OF SODIUM NITRITE ON BODY TEMPERATl.JRE AND 
BRAIN LEVELS OF GAMMA-AMINOBUTYRIC ACID AT 
TWO AMBIENT TEMPERATURES IN MICE 
Rectal temp. 
Ambient 
Temp. 
( oc) 
Mean + S.E. (N) 
2 Control 1 Treated 
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p 
. (oc) 22 38.4±0.2 ( 8) J5.J+O.J ( 8) < 0.005 
umoles GABA/g 
brain 
Source 
Ambient Temp. 
Sodium Nitrite 
TxSN 
Error 
JO 
22 
JO 
(T) 
(SN) 
37.8+0.2 (7) 37.5+0.l (7) >0.05 
2.51±0.17 (8) 3.JJ+0.11 (8)<0.005 
2.19±0.12 (7) 2.32+0.16 (7)>0.05 
Analysis of Variance 
df' MS F p 
l 3.524 18.899 < o. 005 
l 1.833 9.832 <O.Ol 
l 0.966 5.180 .(0.05 
28 0.186 
Jl 
1. Sodium nitrite ( 100 mg/kg )injected intraperi toneally 
J O minutes prior to freezing in liquid nitrogen. 
2. Distilled water (10 ml/kg) injected intraperitoneally 
JO minutes prior to freezing. 
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increase in brain GABA c a used by sodium nitrite at 22°C was 
absent at the higher ambient temperature. 
Data summarized in Table 5 also describes the effect 
of sodium nitrite on rect a l temperature of mice at two am-
bient temperatures, 22 °C and J0°C. It can be seen that so-
dium nitrite produced a significant reduction in body tem-
perature at 22°C ambient temperature. The peak effect on 
body temperature occurred a pproximately JO minutes after 
nitrite injection. Howev er, hypothermia due to sodium ni-
trite at 22°C was prevented at J0°C ambient temperature. 
Similarly, elevation in brain GABA-levels caused by sodium 
nitrite at 22°C was abs c.nt at the higher ambient tempera-
ture. 
The analysis of v ariance surrunarized in Table 5 show 
the effect of two fac t ors , namely, ambient temperature and 
sodium nitrite, and their interactions on brain GABA-
levels. It can be seen that both ambient temperature and 
sodium nitrite had a significant effect on brain levels of 
GABA. Also, there was a significant interaction between 
ambient temperature and sodium nitrite for their effect on 
brain GABA-levels. These data indicate that J0°C pre-
vented the increase in GABA caused by sodium nitrite at 
the lower ambient temp e rature. Furthermore J0°C by it-
self caused reduction of brain GABA-levels in control ani-
mals as compared to the control animals exposed at 22°C 
ambient temperature. 
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J. Effect of Pargyline on Barbital Induced-Narcosis, Body 
Temperature and Brain Gamma-Aminobutyric Acid at Two Ambient 
Temperatures 
At both 22°C and J0°C ambient temperature, pargyline 
(100 m@/kg, i.p., 2 hr pretreatment) potentiated narcosis 
induced by biologically stable barbiturate (barbital), pro-
duced hypothermia and elevated brain levels of GABA (Table 
6). These effects were statistically significant in all 
cases. However,the magnitude of the effects produced by 
pargyline differed at both the ambient temperatures. At 
22°c, pargyline produced nearly 2-fold greater potentiation 
of narcosis due to barbital and a 2-fold greater decrease 
in rectal temperature of mice as compared to J0°C ambient 
temperature. The elevation in brain levels of GABA was 
also greater at 22°C as compared to the higher ambient tem-
perature (Table 6). 
Pretreatment of mice with various doses of pargyline 
at 22°c ambient temperature caused a marked reduction in 
body temperature, reaching a maximum drop of J-6° with 
100 mg/kg and 6.1° with 200 mg/kg dose (Figure 8). At 
J0°C ambient temperature, the drop in body temperature due 
to pargyline was only one half of what was seen during 
pargyline treatment at 22°C, and reached a maximum drop of 
1.8° with 100 mg/kg and J.8° with 200 mg/kg dose (Figure 8). 
The analysis of variance summarized in Table 6 shows 
the effect of two factors, namely, ambient temperature and 
pargyline, and their interaction on brain levels of GABA. 
+~f'f R 
EFFECT OF PARGYLINE ON BARBITAL NARCOSIS, BODY TEMPERATURE AND BRAIN LEVELS 
1 1 · 1 1 · , • 1 , 11 1 ' • ' • \ 1 1 ~ 1 • " r 1 1 1 ' • 1 1 1 ' 1 '· , ' 1 1 " , 1 1, 1 1 • " 11 .. 1 1 · 1 · 1: A 1 1 11 : 1 A 1 • 1 1 1 11: ,, 1 : • 1 1 1 1 1 
OF GAMMA-AMINOBUTYRIC ACID AT TWO AMBIENT TEMPERATURES IN MICE 
I I I ' ... I' I \ \ 'l I "'"I' I I ' ' ,, . I II· I\ 1\ ~ ll 1 I I ~· I I I ·' I i ' I l ,'o\ I I ' I ' l l " 'I l I I 
+ {N} Ambient Mean 7 S.E. % Temp. 2 l Change ( oc} Control Treated 
Barbita13 22 (7) 261.±1.5.0 a (8) 102 129.±lJ.l 
Narcosis 
(min) 
JO 102.±11.7 ( 8) 161.± 8.7a (8) .58 
Rectal Temp. ( oc) 22 J8.7.±.0.l (6) J4.8.±0.5b (6) 10 
JO JS. 4+0 .• 1 ( 6) J6.7.±0.lb ( 6) 4 
umoles GABA4/g 
Brain 22 2.2.s+o.09 (7) 2.88.±.0.lOb (7) 28 
. JO 2.29+0.ll (7) 2.79.±.0.l4c (7) 21 
0\ 
0 
Table 6 (Continued) 
Analysis of Variance of Data on the Effect of Ambient Temperatur~ and 
Pargyline on Brain Levels of Gamma-Aminobutyric Acid 
Source df MS F p 
--· 
Ambient Temp. (T) 1 0.006 0.068 > 0.05 
Pargyline (P) 1 2.228 22.152 <:. o. 001 
TxP 1 O.OJO 0.300 >0.05 
Error 24 0.100 
27 
1. Pargyline (100 mg/kg) injected intraperitoneally 2 hours prior to 3 or 4. 
2. Distilled water (lO ml/kg) injected intraperitoneally 2 hours prior to J or 4. 
J. Barbital (JOO mg/kg) injected intraperitoneally. 
4. Mice were frozen in liquid nitrogen before the determination of brain GABA. 
Control vs. Treated: a p <.0.001 b p < 0.005 c p < 0.02 
O'\ 
I-' 
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TABLE 7• 
EFFECT OF VARIOUS DOSES OF PARGYLINE ON MOUSE BRAIN LEVELS 
OF GAMMA-AMINOBUTYRIC ACID AT 22°C AMBIENT TEMPERATURE 
Pargyline 1 umoles GABA/g % brain 
(mg/kg) mean ± s.E. (N) increase p 
None 2 2.20±0.05 (6) 
25 .: 2.32±0.12 (5) 5 > 0.05 
50 2.64±0.09 (5) 20 < 0.005 
100 _ 2.90+0.12 (6) 31 < o. 001 
200 : 3.08+0.13 (5) 39 <0.001 
1. Pargyline injected intraperitoneally 2 hours prior to 
freezing in liquid nitrogen. 
2. Distilled water (10 ml/kg) injected intraperitoneally 
2 _hours -prior to freezing. 
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Figure 8. EFFECT OF PARGYLINE (mg/kg intraperitoneally) 
ON RECTAL TEMPERATURE OF MICE AT TWO AMBIENT TEMPERATURES. 
Pargyline was administered 120 minutes prior to the measure-
. ment of rectal temperature. Each poi nt represents mean 
± S.E. of 6 animals. Open symbols denote significant dif-
ference (p<0.01) from saline controls. 
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Figure 9. EFFECT OF VARIOUS DOSES OF PARGYLINE ON MOUSE 
BRAIN LEVELS OF GAMMA-AMINOBUTYRIC ACID AT 22°C AMBIENT 
TEMPERATURE. Pargyline was administered 120 minutes prior 
to sacrifice. Each point represents the mean ± S.E. 
Numbers in parentheses represents number of animals used. 
Open symbols denote significant (p<0.05) difference from 
controls. P value represents rejection of the hypothesis 
that the correlation coefficient (r) equals zero. 
Pargyline had a significant effect on brain GABA, while am-
bient temperature on pargyline and ambient temperature failed 
to affect brain levels of GABA. These data indicate that 
J0°C did not prevent the increase in GABA caused by pargyl-
ine at the lower ambient temperature. Further, the higher 
ambient temperature by itself failed to affect brain GABA-
levels of control animals. 
Since an optimum drop in body temperature was observed 
120 minutes after pargyline injection, this time period was 
used to investigate the effect of various doses of pargyline 
on brain GABA-levels. Actual means, standard errors, levels 
of signifi cance and percent increase in brain GABA are shown 
in Table 7. Figure 9 illustrates the dose-dependent effect 
of pargyline on brain GABA-levels. There was a significant 
correlation (r = 0.76, p (0.005) between the dose of pargyl-
ine and elevation of brain GABA. 
D. SOCIAL DEPRIVATION 
Since prolonged social deprivation has been reported 
to lower the neuronal sensitivity of mice to barbiturates 
(Baumel, ~al., 1970a), we measured brain levels of GABA 
following different intervals of social deprivation. 
1. Effect of Social Deprivation on Brain Gamma-amino-
butyric acid 
Data summarized in Table 8 shows the effect of so-
cial deprivation on mouse brain GABA-levels. Social 
deprivation for one day or seven days did not affect brain 
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TABLE 8 
EFFECT OF SOCIAL DEPRIVATION OR SOC~L INTERACTION 
ON. MOUSE BRAIN LEVELS OF GAMMA-AMIN ~UTYRIC ACID 
Days -
of' 
Social 
Environment 
60 : 
150 
umoles GABA/g brain 
me an + S • E • ( N ) 
Social 2 Social l % Interaction · Deprivati&llllll- Change P 
2.44+0.lJ (7) 2.4J±O.o6 (7) 0.4 >0.05 
2.J0±0.08 (8) 2.24±0.15 (8) 3 ~0.05 
2.65+0.12 (8) 
2.75+0.08 (7) 
2.55+0.08 (7) 
2.59±0.07 (8) 
2.61±0.16 (6) 
2.01±0.09 (8) 
2.22±0.14 (7) 
2. OJ±0.11 ( 7) 
2.06+0.09 (8) 
1.99±0.14 (6) 
23 <0.005 
20 .(0.01 
20 <0.01 
20 {0.005 
24 < o. 02 
1 • . Housed 1 to a cage. 
2. Housed 10 to a cage. 
TABLE .9 
EFFECT OF SOCIAL DEPRIVATION OR SOCIAL INTERACTION ON MOUSE BRAIN LEVELS OF 
GAMMA-AMINOBUTYRIC ACID, GLUTAMIC ACID DECARBOXYLASE, 
GAMMA-AMINOBUTYRIC ACID TRANSAMINASE AND PROTEIN 
Mean + S.E. (N) 
Measurement Social Days of Social Environment 
-Environment 1 7 JO 
GABA Interaction 2.44+0.13 (7) 2.J0+0.08 (8) 2.75.±.0.08 (7) 
umoles/g 
2.4J.±.0.06b 2.24.±.0.15b 2.22+0.14a Brain Deprivation (7) ( 8) (7) 
GAD 
umoles co2/g Interaction 10.17+0.45b ~~~ 10.52.±.0.87b ~~~ 10.47+0.77 ~~~ - a Brain/hr Deprivation 10,JJ.±.0.68 10.10.±.0.96 7.02.±.0.80 
umoles co2/mg Interaction - - 265 .±. 19~ 
m Protein 270 + 16 Deprivation - - 2Ql + 25~ 230 + 18 
GABA-T Interaction 
- -
227 .±. 8.4 ( 7) 
umoles/g Deprivation 
- -
228 .±. 9.6b ( 7) Brain/hr 
Protein Interaction - - J9.4+0.0J (16) 
mg Protein/g J5.2.±.0.o4a(l5) Brain Deprivation 
- -
0\ 
--l 
T~Rt~ 9 ~P~nrfnH~~~ 
Analysis of Variance of Data on the Effect of Social Deprivation on 
i \ll, • I\. i Spebif:i'.c I .Activ:fty 1 of ' the GtutJitiiic ' Acid Decarbo~yta~e 'I " ' ' " 1 ' 
I If ' I I I ' 1\ ' I I \ I I I I I I ' I I I 11 1 I ( \ • I • I I '· • I I I .. ' I I 
Source df MS F p 
Interaction vs. Deprived 1 15980 6.55 <0.02 
Replicates 1 1596 0.65 >0.05 
Interaction 1 832 0.34 >0.05 
Error 20 2438 
23 
1. Interaction: housed 10 to a cage; Deprivation: housed 1 to a cage. 
Interacted vs. Deprived 
a b p ( 0.01 p > 0.05 
c. d. Represents values obtained from two separate experiments. 
0\ 
(X) 
GABA, but social deprivation for fourteen days resulted in 
a significant reduction in brain GABA levels. Furthermore, 
the levels of GABA remained depressed, while there was no 
further depletion in GABA, when the social deprivation was 
continued for longer periods of time (Table 8). 
The effect of social deprivation on the GABA synthe-
sizing enzyme, GAD, and the GABA degrading enzyme, GABA-T, 
is shown in Table 9. The social deprivation for thirty 
days resulted in a significant reduction in GAD activity 
(expressed as umoles of co2/g brain/hr). The specific ac-
tivity of the enzyme (expressed as runole~ co2/mg protein) 
was also significantly reduced (Table 9), suggesting that 
the effect was specific to the enzyme. Thirty days of so-
cial deprivation also lowered total protein content of the 
brain (Table 9). The activity of GABA-Twas not affected 
by social deprivation (Table 9). 
E. DRUG WITHDRAWAL 
It is now well known that abrupt withdrawal follow-
ing chronic barbiturate (Essig and Lam, 1968) or ethanol 
(Freund, 1969) administration results in a typical with-
drawal syndrome. This syndrome due to barbiturate or al-
cohol withdrawal is essentially characterized by CNS hyper-
excitability, which is observed in the form of convulsions. 
Barbiturate withdrawal, has previously been reported 
to lower the CNS sensitivity to barbiturates (Wahlstrom, 
1971). In the present study, with the help of biologically 
stable barbiturate (barbital ), we found that alcohol with-
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drawal _also lowers the neuronal sensitivit y to barbiturates 
(Table 12). These findings suggested that barbiturate or 
alcohol withdrawal induced CNS hyperexcit a~ility is also 
accompanied by an alteration in CNS sensitivity to bar-
biturates. Tiierefore, we measured brain GABA-levels 
following barbiturates and alcohol withdrawal. Since 
barbiturate or alcohol withdrawal induced CNS hyperexcita-
bility returns -to normal over a period of time, we also 
measured GABA-~evels after the hyperexcitability had re-
gressed ~ to . see if the GABA-levels were back to control values. 
1. Barbiturate Withdrawal 
Symptoms 
Approximately 16-24 hours following the barbiturate 
withdrawal, eight out of ten animals showed convulsions upon 
exposure to an auditory stimulus (lOOdB f or JO seconds). 
Control mice did not show any signs of convulsions upon 
their . exposure to the stimulus. 
Up9n the exposure of the withdrawn animals to the 
stimulus -it was found that, most of the convulsions were 
associated with loss of upright posture, and they were 
generalized tonic-clonic seizures of less than a minute 
duration •. . Occasionally such convulsions lacked a clonic 
phase, . and infrequently a mouse would remain upright while 
generalized shaking mov ements occurred. The last absti-
nence convulsions occurred from 42 to 48 h ours after the 
barbiturate was discontinued. 
Hours of 6 Withdrawal 
24 
48 
120 
TABLE 10 
EFFECT OF BARBITURATE WITHDRAWAL ON MOUSE BRAIN LEVELS 
2 Untreated 
1.78+0.09 (8) 
1.6J.±,0.1J {8) 
2.57+0.21 {8) 
OF GAMMA-AMINOBUTYRIC ACID 
umoles GABA/g Brain 
Me an + S • E • ( N ) 
Chronic Phenobarbital Treated1 
ConvulsedJ 
1.72.±,0.11 (8) 
l.J4.±,0.17 (J) 
Non-Convulsed ~ 
1.82.±,0.08 {8)5 
l.4J+0.14 (5) 
2.54+0.15 {8) 
p 
>0.05 
>0.05 
>0.05 
1. The animals received phenobarbital sodium in drinking water, together with 
20 mg/100 ml saccharin to mask the bitter taste of the barbiturate, in in-
creasing doses over a period of four weeks. The initial dose was 50 mg/kg/day 
and was increased weekly until the animals rec_eived 400 mg/kg/day. During 
withdrawal mice were given plain drinking water. 
2. Untreated animals received saccharin, 20 mg/100 ml in drinking water for four 
weeks. Saccharin solution was replaced by plain drinking water when pheno-
barbital was withdrawn from the chronically treated animals. The animals 
were then exposed an auditory stimulus {100 db for JO seconds) before freez-
ing in liquid nitrogen. 
J. The animals showed convulsions within JO seconds of exposure the stimulus and 
were then frozen immediately. 
-'I 
I-' 
~A~~f tR ~y~~rt~~~9~ 
4. Convulsions were not observed within 60 seconds of exposure to the "stimulus 
I. ~fia 1rhm~tii'.ately' a'.f''t~r " ~hat mlce ' were ft:ozeh'.'" ' 1 .. 1 ' • I ' " '" , . I 1 1" I .,. ' 1 ' 
+I • · I , ,., . I' i I I I ,I I I, . I j 1, 1 I I I. I l' •• I' 
5. The animals were sacrificed 24 hours following the withdrawal without any 
exposure the stimulus. 
6. Different withdrawal hours at which mice were frozen in liquid nitrogen. 
-.J 
I\) 
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2. Effect on Brain Gamma-aminobutyric Acid 
The effect of barbiturate withdrawal on mouse brain 
GABA-levels is summarized in Table 10. It demonstrates that 
24 or 48 hour withdrawn animals did not differ in brain GABA-
levels from untreated animals. Similarly, there was no dif-
ference in brain GABA-levels whether these withdrawn animals 
showed convulsions or not. It can also be seen in Table 9 
·that 120 hour withdrawn animals did not show any convul-
sions and that their brain levels of GABA did not differ from 
untreated animals. 
J. Ethanol Withdrawal 
Symptoms 
The maximum intensity of the syndrome was seen in be-
tween 5-8 hours following removal of mice from the chamber. 
Table 11 shows the grading system for assessing the sever-
ity of the withdrawal reaction. During the withdrawal, 
almost all signs of the typical withdrawal syndrome 
(Goldstein, 1972) were seen; these were: a) spontaneous 
convulsions, or convulsions elicited either by an auditory 
stimulus (buzzer used in conditioning apparatus) or by a 
sharp tap on the cage or by holding the mouse up by the 
tail, b) lethargy, c) tremor, and d) "tail lift." 
The most useful sign to detect the withdrawal in-
duced CNS hyperexcitability was susceptibility of mice to 
audiogenic seizures; all 5-8 hour withdrawn animals showed 
either mild clonic- or severe clonic-tonic convulsions upon 
exposure to the auditory stimulus. The syndrome then re-
gressed slowly over the next 24 hours. 
4. Effect on Brain Gamma-Aminobutyric Aci d 
.Data summarized in Table lJ demons t rate the effect 
of ethanol withdrawal on brain GABA-levels. The maxim 
severity of withdrawal symptoms on (Table 11) as well as 
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an alteration in CNS sensitivity to barbi al were (Table 12) 
observed 8 hours following withdrawal, at which time brain 
GAB.A-leve·ls -were significantly reduced. Animals which 
were withdrawn for 5 or 24 hours and those immediately re-
moved from the chamber did not show as severe a withdrawal 
sy:ridrome and they did not differ f~om controls with re-
spect ~ to levels of brain GABA. 
Because pyrazole is toxic (Lelbach, 1969), we were 
concerned about its contribution to the withdrawal induced 
alteration in barbital narcosis (Table 12 ) and brain levels 
of- GABA (Table lJ). We, therefore, treated mice with simi-
lar: doses of pyrazole, for four days as during the actual 
experiment but without exposure to ethanol , and measured 
their response to barbital and their brain levels of GABA 
(Table - 14). It can be seen that pyrazole alone did not 
produce any significant alteration in narcosis due to barbi-
tal ~ or : in brain levels of GABA. 
l 
1 
I 
I 
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TABLE 11 
ETHANOL WITHDRAWAL SYNDROME 
Degree of Abstinence Number of 
Signs S~drome animals that showed 
Mild Moderate Maximum withdrawal reaction 
Lethargy c 7b Jb ob 10/12 
Tremor d 4 2 J 9/12 
Tail lifte 4 2 0 6/12 
stc;i-rtt-e to 
noise J 4 J 10/12 
Audiogenic 
seizuresg 0 4 8 12/12 
Convulsions on 
handlingh 0 6 4 10/12 
Spontaneous 
convulsionsi 4 0 0 4/12 
a'l'he mice were removed from the ethanol vapour chamber 24 
hours after their last dose of pyrazole. The maximum in-
tensity of the syndrome was seen in between 5 and 8 hours. 
The syndrome then regressed slowly over the next 24 hours. 
The animals were observed continuously for 10 hours with 
scores recorded hourly. Thereafter, observations were 
made at longer intervals. Control animals did not show any 
signs of withdrawal reaction. The following controls were 
run: 1. Six mice were exposed to air (without alcohol) in 
an identical chamber and were given pyrazole for 4 days, 
2. Ten mice were exposed to alcohol vapours for 4 days, 
but were not given pyrazole. 
bNumber of animals. 
cMild: slow movement, Moderate: slow movement + dragging 
limbs, Maximum: No movements at all. 
dMild: twitching, Moderate: occasional trembling, Maximwn: 
continuous tremors for 5-8 seconds. 
e"Tail lift" was defined as raising the tail over the back, 
one of the abnormal postures used in Freund's (1969) g r a d-
ing of the withdrawal signs in mice. Mild: 1 tail lift/60 
minutes, Moderate: 2 tail lif't/60 minut es, Maximum: J-4 tail 
lift/60 minutes. 
£Startle to noise was elicited by a sharp tap on the cage 
or table. Mild: Twitch lasting for about 2 seconds, 
Moderate: twitch accompanied by jumping, Maximum: Twitch 
followed by tonic convulsions. 
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gExposure of animals to a buzzer (generally used in a con-
ditioning apparatus) produced convulsions within 3 seconds. 
Moderate: mild clonic convulsions only. Maximum: severe 
clonic-tonic convulsions (4 out of 8 animals died). 
hConvulsions on handling was defined as h«»lding the mouse 
up by· the tail. The mouse arched his baclt, tightened his 
facial _muscles into an abnormal grimace amd jerked or 
twirled violently. Moderate: tightening ®f the facial 
musele, . jerking and twirling, Maximum: tiWitening of the 
facial _muscle, jerking, twirling and continue to convulse 
when .replaced in the cage. 
iMild: tonic, jumping1 Moderate: one or tvo generalized 
tonic-elonic convulsions per hour, Maximtm: three or more 
generalized tonic-clonic convulsions per hour. 
77 
TABLE 12 
DURATION OF BARBITAL NARCOSIS IN MICE WITHDRAWN 
FROM ETHANOL 
Hours of Withdrawal Barbital
1 Narcosis, Duration % Syndrome Min + S.E. {N} Withdrawal2 Intensity Control4 Ex2erimental3 
Change 
8 3 140+8.4 (8) 56+6.la (8) 150 
24 1 132.±9.9 (7) 95.±6.5 b (6) 28 
1. JOO mg/kg injected intraperitoneally. 
2. Number of hours after removal of mice from the ethanol 
vapour-chamber, at· which time they were tested with 
barbital. 
J. Prior to withdrawal, mice were given 0.5 umole/kg of 
pyrazole, i.p., at o, 24, 48 and 72 hours during the 
total of 96 hours of continuous exposure to an air-
ethanol (10 mg ethanol/l i ter air) mixture. 
4. Controls were exposed concurrently to an air flow 
{without ethanol) in identical chamber. 
5. Numerical grading of the withdrawal syndrome {l<J). 
Control vs. Experimental 
a p~0.001 
b p < 0.02 
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TABLE 13 
EFFECT OF ETHANOL WITHDRAWAL ON MOUSE BRAIN LEVELS 
OF GAMMA-AMINOBUTYRIC ACID 
Hours Withdrawal umoles GABA/g Brain 
of' 1 Syndrome p 4 J Experimental2 Withdrawal Intensity Control 
o ~ 0 2.48.±,0.0 (7) 2.56+0.09(7) >0.05 
5 : 2 2.55+0.11(7) 2.46+0.12(7) > 0.05 
8 ~ 3 2.55+0.11(7) l.80+0.14(7) < o. 005 
24 1 2.J8+0.o8(7) 2.36.±.0.08(7) > 0.05 
1 • . Nll.mber : of' hours af'ter removal of' mice f'rom one ethanol 
vapour-chamber, at which time they were f'rozen in 
liquid nitrogen. 
2. Prior to withdrawal, the animals were given 0.5 umoles/ 
kg of' pyrazole, i.p., at O, 24, 48 and 72 hours during 
the total of' 96 hours of' continuous exposure to an 
air-ethanol (10 mg ethanol/liter air) mixture. 
J. Controls were exposed concurrently to an air-f'low 
(without ethanol) in identical chamber. 
4-. . Nrimerical grading of the withdrawal syndrome (1 2 J). 
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TABLE 14 
EFFECT OF PYRAZOLE ON BARBITAL NARCOSIS AND BRAIN LEVELS 
OF GAMMA-AMINOBUTYRIC ACID IN MICE 
Testi2g Ethan~l 
Mean + S.E. (N) 
Control Experimental 
p 
Hour Hour 
Barbita14 32 8 111+8.6 (8) 104±9.8 (8) )0.05 
Narcosis 
(min) 
48 24 . 116+7.2 (8) 107+6.8 ( 8) >0.05 
umoles GABA/g 
brain 32 8 2.46+0.09(8) 2.43+0.10(8)>0.05 
. -
1. Pyrazole (0.5 umole/g) injected intraperitoneally once 
a day for four days. 
2. Nwnber of hours after the last injection of pyra zole, 
at which t i me mice were tested with barbital or frozen 
in liquid nitrogen for the determination of brain GABA. 
J. Nurnber of hours corresponding to ethanol withdrawal. 
4. JOO mg/kg injected intraperitoneally. 
DISCUSSION 
't'- ; 1i no butyric acid (GABA) has been .shown to play 
a role as a specific inhibitory transmitter in several 
areas of the mammalian brain (Krnjevic and Schwartz, 1967; 
Obata et al., 1967; Otsuka, 1972; Galindo et al., 1967) . 
The non-specific depressant ef.fe.~ts of GABA on the mam-
malian CNS have also been demonstrated in various labora-
tories (Iwama and Jasper, 1957; Bhaegava and SriYastava, 
1964). Of all the depressant amino-acids present in the 
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mammalian central nervous system, GABA occurs in the larg-
est amounts; moreover, it occurs m1iquely in nervous tissue 
(Cooper et al., 1970) . Further, unlike th& monoamines, the 
concentration of GABA found in the mammalian central ner-
vous system (CNS) is in the order o~ um~les/gm rather than 
nmoles/gm. These findings suggest that , an increase in 
brain levels of GABA due to a specific treatment should re-
duce the CNS excitability in a way that the sensitivity of 
the CNS neurons to respond to a depressant drug would be 
enhanced and vice versa. Therefore, to test our hypothesis, 
we selected a variety of conditions or tre~tments already 
known to either enhance or to reduce the sensi t :!.vi ty of the 
CNS to drug-induced depression and .subjected our animals to 
the same treatments and measured their brain GABA-leve .l s , in 
order to investigate a relationship. 
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Acute exposure of mice to hypoxia has been reported 
to enhance the CNS sensitivity to barbiturates (Baumel et 
al., 1970b). The potentiation of narcosis due to barbital, 
which is excreted wunetabolized (Ebert et al., 1964), under 
hypoxia was greater at 22°C than at J0°C ambient tempera-
ture (Baumel et al., 1970b). The hypoxic exposure has also 
been sho;vn to antagonize convulsions induced by semicarba-
zide or methionine sulphoximine (Baumel ~al., 1969a, b), 
both drugs decrease brain GABA-levels (Killam and Bain, 
1967; Roberts and Frankel, 1951). Data obtained in the re-
search investigation showed that hypobaric exposure elevates 
brain GABA at both (22 and J0°C) ambient temperatures 
(Table 1). Thus, the duration of hypoxia exposure or am-
bient temperature does not affect or interact with the ef-
fect of' low ambient oxygen on brain GABA. However, it can 
be seen in Table 1 that the increase in GABA is compara-
tively greater, the cause of which is not clear at present, 
when mice are exposed to hypoxia at the lower ambient temper-
ature. 
Breathing of hypoxic air can lead to impairment of 
brain oxidative metabolism (Gurdjian e~ al., 1949) with 
possible reduc"t;ion in the use of GABA in the shunt pathway 
of the Kreb's cycle. This causes an increase in brain 
levels of GABA (Wood et al., 1968), since the formation of 
the aminoacid by the anarobic enzyme glutamic acid decar-
boxylase (GAD) is unlikely to be impaired by lack of oxygen 
(Wood et al., 1968). 
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Increase in levels of brain GABA have been related to 
a reduction in neuronal excitability (Bennett et al., 1963). 
Therefore, we suggest that hypoxia induced elevation in 
brain GABA causes reduction in brain excitability, which in 
turn facilitates drug induced depression. 
DMI has been reported to elevate the brain sensitivity 
to barbiturates at 22° but not at J0°C ambient temperature 
(Shah and Lal, 1971). TI-... is effect of DMI on the brain se!l-
si tivi ty was related to its hypothermic ef:fect (Shal and Lal, 
1971). Thus, DMI produce3 hypothermia and potentiates nar-
cosis due to barbital at 22° but not at J0°C ambient temper-
ature. Our data on DMI's effect on body temperature at both 
the ambient temperatures (Table 3) is in agreement with the 
above finding. It was also found that DMI, ambient tempera-
ture or their interactions had significant effect on brain 
GABA-levels. Thus, DMI caused elevation in brain GABA at 
22°C but not at the higher ambient temperature (Table J). 
Since J0°C ambient temperature al30 prevented DMI induced 
hypothermia, it appears that hypothermia due to DMI causes 
accumulation of brain GABA. In fact, hypothermia has pre-
viously been reported to raise brain GABA-levels (O,ja et 
al., 1968). Furthermore, DMI produces a dose dependent 
hypothermia at 22°C (Shah and Lal, 1971), and our data 
show that there was a dose-response relationship between 
the dose of DMI administered and the degree of elevation in 
brain GABA (Table 4, Figure 7). Considering the aforemen-
tioned observations, we suggest that hyJ:bthermia induced 
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by DMI elevates the brain levels of GABA, resulting in 
lowered neuronal excitability to be reflected in enhanced 
barbiturate action. 
Sodium nitrite lowers the threshold of brain neurons 
to drug induced depression at 22 but not at J0°C ambient 
temperature (Baumel et al., 1971). Like DMI, sodium ni-
trite produced hypothermia and potentiated narcosis due to 
barbital at 22° but not at J0°C ambient temperature (Baumel 
et al., 1971). However, this effect of sodium nitrite on 
the brain sensitivity was not related to its hypothermic 
effect, since direct intracerebral injections of sodium ni-
trite failed to affect body temperature and narcosis due to 
a barbiturate (Baurnel ~t al., 1970). Instead, Baumel et al. 
(1970), related the effects of sodium nitrite on brain ex-
citability and body temperature to its hypoxic effect, be-
cause sodium nitrite induces methe·moglobinimia (Bodansky~ 
1951) which in turn impairs the delivery of oxygen to the 
tissues (Darling and Roughton, 1942), cases hypoxia. In 
the present study, sodium nitrite elevated brain levels of 
GABA and produced hypothermia at 22°C; these effects were 
abolished at J0°C ambient temperature (Table 5). Further 
support that GABA may be involved facilitating sodium ni-
trite induced alteration in the threshold of brain neurons, 
comes from the following findings of Baumel et al (1971, 
1970), 1) sodium nitrite-induced poi;entiation of barbitu-
rate narcosis was prevented by hyperbaric oxygen (OHP), and 
2) sodium nitrite antagonized convulsions induced by semi-
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carbazide, both OHP (Wood et al., 1963) and semicarbazide 
(Killam and Bain, 1967) reduce brain GABA-levels. These 
observations suggest that hypoxia induced by sodium nitrite 
causes -accumulation of brain GABA, resulting in lowered 
neuronr-.1 excitability to be reflected in enhanced barbi tu-
rate action. 
Treatment of mice with pargyline at 22°C and at J0°C 
ambient temperature enhances the narcosis due to barbital 
(Table -6), a drug excreted unmetabolized (Ebert et al., 
1964), and lowers body temperature (Table 6). Further, 
p~rgyline also produces a dose-dependent hypothermia at 
both the ambient temperatures (Figure 8). These observa-
tions ~ suggest that pargyline's ability to enhance neuronal 
sensitivity to barbiturates is due to its hypothermic ef-
fect. However, our data on pargyline's effect on brain 
GABA (Table 6) show that it also raises brain GABA-levels 
at both the ambient temperatures. Moreover, there was a 
dose-response relationship between the amount of pargyline 
administered and the degree of elevation in GABA (Table 7, 
F1g~re 9). Pargyline has previously been shown to elevate 
brain levels of GABA in mice (Schatz and Lal, 1971). There-
fore, .we suggest that hypothermia induced by pargyline 
causes elevation in brain GABA, resulting in lowered neu-
ronal _excitability to be rer~lected in enhanced ba.rbi tura-ce 
aetion • . 
The ability of pargyl i ne or DMI to elevate brain 
GABA may at f irst se e m paradoxical since they are used as 
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antidepressants, whereas GABA has neuronal inhibi t ory pro-
perties. It may be that GABA is not involved in mood; 
pargyline's or DMI's effect on GABA is, therefo re , no t re-
lated to their ability to combat depression. Also, our 
study involved the administration of only a single dose 
of pargyline or DMI and is, therefore, short term in na-
ture, whereas chronic administration of these drugs is 
required for their ability to exhibit their antidepressant 
effect. 
Baumel et al. {1970) reported that chronic social 
deprivation raises arousal levels of mice such that their 
susceptibility to CNS depressants is reduced. This would 
predict enhanced effectiveness of CNS stimulants. In fact, 
chronically isolated mice are hypersensitive to various 
stimulants {Consolo et al., 1965; Welch and Welch, 1966). 
The biochemical bases of the higher arousal due to social 
deprivation is not known. Circmnstantial evidence may im-
plicate the involvement of brain serotonin. Higher levels 
of brain serotonin cause CNS depression {Jouvet, 1968), 
while low brain serotonin is associated with insomnia 
(Delorme et al., 1966). Social deprivation was found to re-
duce brain serotonin turnover (Garrattini et al.~ 1967; 
Giacalone et al., 1968; Valzelli and Garrattini, 1969; 
Welch and Welch, 1968). In contrast, barbiturates and 
chloral hydrate increased the concentration of serotonin 
(Anderson and Bonnycastle, 1961). '11lus, the opposing ef-
fects of social deprivation and the CNS depressants on 
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brain serotonin could result in the pharmacological antago-
nism of these drugs. Lal et al. (1972) reported that deple-
tion of brain serotonin after social manipulation did not 
alter the sensitivity of either socially deprived or social-
ly interacted mice to hexobarbital. Since the arousal levels 
may be related to an altered concentration of an inhibitory 
transmitter and/or non-specific depressant substance, we 
measured the GABA levels in the brains of mice after they 
were subjected to living conditions of social deprivation 
and social interaction. Data presented in Table8 show that 
brain GABA concentrations differed significantly in two 
groups. The socially interacted group showed higher brain 
GABA than the socially deprived group. Therefore, we sug-
gest that GABA plays an important role in the control of 
CNS arousal as altered by social deprivation or interaction. 
The reduction in GABA activity as in socially deprived 
mice would be expected to reduce inhibition, or facilitate 
activation, resulting in an elevated arousal-level. 
The cause of lower than normal GABA levels as in 
socially deprived mice could be either 1) an inhibition of 
the enzyme synthesizing GABA, glutamic acid decarboxylase 
(GAD); or 2) a stimulation of the enzyme degrading GABA, 
GABA-alpha-keto glutaric acid transaminase (GABA-T); or 
J) changes in permeability of membranes to GABA which al-
low the amino acid freer access to the GABA-T enzyme system. 
Alternatively, a combination of two or more of these possi-
bilities may be involved in lowering GABA following social 
deprivation. 
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We, theref'ore, measured the activities of' the GAD and 
GABA-T in mouse brain to elucidate the mechanism of' decrease 
in GABA f'ollowing social deprivation. The activity of' GAD, 
the GABA synthesizing enzyme (Baxter, 1970), was f'ound to be 
specif.ically lowered af'ter thirty days of social deprivation, 
even though there was a small but signif'icant decrease in 
total protein content of' the brain (Table 9). The activity 
of' GABA-T remained unaltered f'ollowing thirty days of' social 
deprivation. The third possibility that altered membrane 
permeability could change brain GABA, remains to be studied. 
Tlieref'ore, we suggest that reduced concentrations of' GABA 
as -seen ic socially deprived mice are true ref'lections of' 
brain GAD activity. 
The abrupt withdrawal of' ethanol following its chron-
ic administration reduces the sensitivity of' the CNS to 
barbital induced depression (Table 12). Barbital was se-
lected f'or the reason that it is excreted urunetabolized 
(Ebert et al., 1964). We measured brain GABA in order to 
es~ablish its relationship with ethanol abstinence-induced 
alteration in CNS sensitivity to barbiturates. To our 
knowledge, the decrease in brain GABA as in ethanol with-
drawn animals (Table 13) has never been reported bef'ore. 
This decrease in GABA was evident only in eight hour with-
dr·awn animals; they exhibited most severe abstinence syn-
drome (Table 13) and a greater degree of' reduction in 
narcosis due to barbital (Table 12), as compared to twent y-
f'our hour withdrawn animals. GABA has previously been 
implicated in regulation of' neuronal excitability (Be nnett 
88 
et al., 1963). Since GABA is an inhibitory transmitter, it 
has also been implicated in the depressant actions of eth-
anol in the central nervous system (Hakinen and Kulonen, 
1961). Considering these properties of GABA, we suggest 
that lower than normal levels of GABA as in ethanol with-
drawn mice causes an increase:in neuronal excitability, which 
is evident in the form of convulsions, so that the potency 
of a depressant drug is altered. 
The use of pyrazole in the ethanol inhalation-exper-
iments requires justification because of its toxicity to 
liver, when given alone or with ethanol (Lelbach, 1969; 
Lieber et al., 1970). _Further, not much is known about 
pyrazole's action in the brain. The dose of pyrazole used 
during these studies was less than 1/8 of the LD50 for mice 
as reported by Goldstein and Pal (1971). To assess the 
role of pyrazole in the withdrawal induced-alteration in 
brain sensitivity to barbiturates (Table 12) and GABA levels 
(Table 13), we administered pyrazole alone for four days as 
during the actual experiment but without ethanol and found 
that it did not have any effect on brain sensitivity or 
GABA levels (Table 14). Also, pyrazole alone did not pro-
duce any of the ethanol abstinence signs listed in Table 11 • 
Since brain levels of GABA in septal lesioned rats 
remained Unaltered (Table 2), it seems that the alteration 
in brain sensitivity to barbiturates as in the lesioned 
rats might not be related to changes in brain GABA-levels. 
Perhaps decrease in the acetylcholine content of the brain 
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occurring after septal lesions (Sorensen and Harvey, 1971) 
might be responsible for the increased sensitivity to bar-
biturates, since acetylcholine functions as excitatory 
transmitter in various regions of the brain (Bradley, 1968). 
Thus, decrease in brain content of acetylcholine could re-
duce the excitability of brain neurons, which in turn may 
be responsible for the increased brain sensitivity to bar-
biturates. 
Data presented in Table 10 shows that brain GABA-
levels of barbiturate withdrawn mice remained unaltered. 
This indicates that GABA may not be involved in barbiturate 
withdrawal induced alteration in brain sensitivity. How-
ever, it is possible that barbiturate withdrawal might 
have altered the rate of turnover of GABA. Or perhaps 
there were small but significant regional changes in brain 
GABA that were not reflected in whole brain assays. 
Finally, our data obtained by utilizing a variety of 
conditions such as acute hypoxia, drug treatments, social 
deprivation or alcohol withdrawal strongly support the 
hypothesis that there is a correlation between brain sensi-
tivity to barbiturates and brain levels of GABA. Thus, 
lowering of the threshold of brain neurons to barbiturates 
caused by hypoxia, desipramine, sodium nitrite or pargyl-
ine treat~ent is accompanied by increase in brain levels 
of GABA, a neurotransmitter at inhibitiory synapses and/or 
a non-specific depressant substance. And, increase in the 
threshold of brain neurons to barbiturates due to chronic 
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social deprivation or alcohol withdrawl is accompanied by 
decrease in brain GABA-levels. The utilization of differ-
ent classes of' drugs with different pharmacological proper-
ties, except for desipramine and pargyline both of which 
possess antidepressant activity but have different mechan-
isms of action, and environmental conditions helps us to 
make a generalized conclusion that brain content of GABA 
plays a very important role in regulating the neuronal 
sensitivity to drugs. We have thus discovered a specific 
biochemical mechanism for alteration in neuronal sensitivi-
ty to drugs. 
Implications of GABA as a specific substance tha.t 
regulates the neurona.l excitability ara many. The prior 
treatment with drugs known to change brain levels of GABA 
may, therefore, be expected to alter the potency of central 
nervous system drugs, sometimes in an undesirable mariner. 
The heightened basal level o f central nervous 5ystem ac-
tivity (elevated arousal) as in socially deprived mice 
(Lal et al., 1972), provides suggestion as to the etiology 
of certain types of schizophrenia. Similar to certain 
schizophrenic patients (Kornetzky and Mirsky, 1962), so-
cially deprived mice are in a state of overarousal and 
are less responsive to the central nervous system depres-
sants (Lal et al ., 1972). Since the deprivation induced 
overarousal is related to deficiency of brain GABA, schizo-
phrenic overarousal could also be :r·e lated to deficiency 
GABA. However, at best these suggestions are only specu-
lative at this time . 
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SUMMARY 
l. Acute exposure to hypoxia elevates brain levels of GABA. 
Low oxygen due to hypoxia causes alteration in brain 
metabolism which leads to accumulation of GABA. Since 
GABA is expected to be involved in the maintenance of 
appropriate levels of excitability in neurons, an in-
crease in GABA concentrations due to hypoxia would cause 
reduction in brain excitability. Thus, lowering thresh-
old of brain neurons to drug induced depression. 
2. Rats with bilateral stereotaxically placed electrolytic 
lesions of the septal area of the basal telencephalon 
demonstrated marked ir..crease :Ln ba~bi tal ir..duced-narco-
sis. The lesions also decreased barbital induction 
time by one half. These observations suggest that pro-
duction of septal lesions en~ances the depression of 
brain neurons. GABA is not involved in septal lesion-
· induced enhancement of neuronal sensitivity to drug 
induced depression. 
J. Injection of desipramine raises brain GABA and lowers 
body temperature. Hypothermia due to DMT is important 
in elevation of brain GABA. Higher than normal ambient 
temperature reduces brain levels of GABA . Higher 
levels of GABA due to DMI induced-hypothermia reduces 
the excitability of brain neurons, so that CNS sensi-
tivity to barbiturates is increased. 
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4. Injection of sodium nitrite elevates brain GABA and 
lowers body temperature. Hypothermia due to sodium ni-
trite is not important in raising brain levels of GABA. 
We suggest that sodium nitrite induced hypoxia elevates 
brain GABA which in turn reduces the neuronal excita-
bility. 
5. ·Potentiation of the activity of barbital by pargyline 
is due to its ability to lower the threshold of brain 
neurons to drug induced depression. Injection of 
pargyline lowers body temperature and raises brain GABA. 
Increase in brain GABA due to pargyline is related to 
hypothermia. Thus, increased levels of GABA reduces 
the excitability of brain neurons to such an extent that 
the potency of CNS depressant drugs is altered. 
6. Mice deprived of social interactions show reduced levels 
of brain GABA. Since GABA is considered to be an in-
hibitory transmitter, reduction in GABA's activity as 
in socially deprived mice would be expected to reduce 
inhibition, or facilitate activation, resulting in an 
elevated arousal level. This elevation in basal level 
of CNS activi ty produces alteration in the potency of 
central nervous system drugs. Reduced levels of GABA 
following social deprivation are true reflections of 
GAD activity. The ac~ivity of GABA-T remains unaltered 
following social depriva t ion. Chronic deprivation of 
social stimuli also lowers the a mount of t o t al protein 
in the brain. 
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7. Mice develop physical dependence on phenobarbital whe n 
their fluid intake is restricted to solutions contain-
ing increasing concentrations of the drug. Following 
withdrawal, convulsions are seen in response to the au-
ditory stimulus. Barbiturate withdrawal-induced alter-
ation in brain sensitivity is not related to changes in 
brain GABA. 
8. Injections of pyrazole stabilizes blood alcohol-levels. 
Intoxicating blood levels of ethanol for several days 
in mice housed in an atmosphere of ethanol vapours pro-
duces physical dependence. Upon removal from the al-
cohol, mice develop spontaneous or the auditory stimu-
lus-induced convulsions. Mice withdrawn from alcohol 
demonstrated marked decrease in barbital induced 
narcosis, suggesting that there is a reduction in sensi-
tivity of brain neurons to drug induced depression. 
Injections of pyrazole alone does not alter brain levels 
of GABA or brain sensitivity to barbiturates. Brain 
GABA-levels decreases following alcohol withdrawal. 
This indicates that reduced levels of GABA increases the 
excitability of brain neurons so that their sensitiv ity 
to depressant drugs is lowered. 
94 
REFERENCES 
Agrawal, H.C., Fox, M.W. and Himwich, W.A.: Neurochemical 
and behavioral aspects of isolation rearing in the dog. 
Life Sci. £:71-78, 1967. 
Anderson, E.G. and Bonnycastle, D.D.: A study of the cen-
tral depressant activity of pentobarbital, phenobarbital 
and diethyl ether in relationship to increase in 5-hydroxy-
tryptamine. J. Pharmacol. Exp. Ther. lJO: 1J8-4J, 1961. 
Awapara, J., Landau, A.J., Fuerst, R. and Seale, B.: Free 
~-amino butyric acid in brain. J. Biol. Chem. 187: J5·· 39, 
1950. 
Ballantine, E.: Effect of GABA on audiogenic seizures. 
Colloq. Intern, Centre. Natl. Rech. Sci. (Paris) 112: 447-
51, 196J. 
Balazs, R., Dahl, D., and Harwood, J.R.: Subcellular dis-· 
tribution of enzymes of glutamat .e metabolism in rat brain. 
J. Neurochem. 11: 897-905, 1966 • .......,,_ 
Baumel, I.P.: Effect of acute hypoxia or c.hronic social 
isolation on brain sensitivity and barbiturate metabolism. 
Ph.D. Thesis, Dept. Pharmacol. Toxicol. University of' Rh.ode 
Island, 1970. 
Baumel, I.P., DeFeo, J.J. and Lal, H.: Alteration in "brain 
sensitivity and barbiturate metabolism ur..relate d to aggres-
sion in socially deprived mice. Psychopharmacologia 18: 
320-24, 1970a. 
Baurnel, I.P., DeFeo, J.J. and Lal, H.: Effect of acute 
hypoxia on brain sensitivity and metabolism of barbiturates 
in mice. Psychopharmacologia 17: 193-97, 1970b. 
Baumel, I.P., Pitterman, A.B., DeFeo, J.J. and Lal, H.: 
Nitrite induced enhancement of neuronal sensitivity to 
barbiturates and deceleration of' barbi tua ,e metabolism: 
Effect of high ambient temperature or oxygen under high 
pressure (OHP). Pharmacologist 1:.J.: 289, L~7l . 
Baumel, I., Robinson, S.M. and Blatt, W.F.: Multi-chamber 
system for toxicity studies in mice at sil1llll.lated high al -
titude. J. Pharrn. Sci • ..2.§_: 918-19, 1967. 
95 
Baumel, I., Schatz, R., DeFeo, J • . J. and Lal, H.: Protec t. ion 
against semicarbizide-indu.ced convulsions in mice at hypo-
baric pressure. J . Pharm . Pharmaco1 . 21: 119-20, 1969a. 
Baumel, I ., Schatz, R., DeFeo, J.J. and Lal, H.: Hypoxia and 
methionine sulpho.ximine seizures in mice . J. Pharm. Pharma-
col. 21: 70J-4, 1969b 
Baumel, I., Schatz, R. , DeF eo, .J.J . and Lal , H .: Protection 
against m- fJ_uorot·yrosine convulsions and lethality in mice 
exposed to hypoba ric hypoxia . J . Fharm . Pharmacol. 21: ,;,75 -
-6, 1969c • 
.;BQ..Xt~r, c . F .: The nature of' garruna-amino butyric acid . In : 
>.:tncib1..:it.JJ:'~-of' Neurocbemist r y ; vol. III, pp . 289 -353, ed . Abel 
... ajtha, Plern.m1 Press , N . Y., 1970. 
Baxter, C.F. and Rober-r.s , E: .: The gamma-amino butyric acid -
alpha-ketoglu~aric acid transaminase of' beef brai~. J. 
Biol. Chem. 23'3: 1135-39, 1958 . 
Bennett, M., Aljure , E ., Narajima, Y. and Pappas , A.D.: 
Elec tronic junc-cions betw.een i.:eleo.st spinal neurons : Electrc-
physiology Ul trastru'.::ture . Science .J:4l: 262-l~ , 196J. 
Bergeret, B., a.nd Chatagne , F .: Sur la presence d'acide 
cystenesulfinique dans le cerveau du rat normal. B:Lochem . 
Biophys. Acta , 14· : 297 , 1954 . 
Bernardini , A. T .: Influence of redu'.::ed pressure on adminis -
tered drugs. Pha.rmacologist ll : 22.J, 1969. 
Bhargava, X.P. and Srivastava , R.K.: Non-specific depressant 
action of gamma - amino butyric acid on s omatic reflexes. 
Brit. J. Pharamcol . ~: J91-98, 1964. 
Bindman, L . J ., Lippold, O. C.J. and Redfearn , J.IV.T.: The 
non-selective blocking action o-f: gamma - amino butyric acid 
on the ser.sory cerebral cortex of th~ rat. J . Phy.siol . 
(Land.) 162: 105-120, 1962 . 
Bodansky, O.: M~themoglobinemia and methemoglobi~ produc -
ing compo;_mde . Pharma.c ol. Rev . J.: 144-96 , 1951. 
Bradley, P . B . : Syna:;;:>tic- transrr.is 5i0n in the central ne:::·vou~ 
system and i ts :r <:· l~vance f "or drug aci::ion . In : Tn.tern.z.t:i_onrt. l 
ReYiew of Neurobiology , Yol. II, e-6.. oy C. C. Pfei f fer a .ad 
J.R. Smythies. pp. 2-53, Academie Press , ~e~ York , 1963 . 
Bµstos, G.O ., Kalant , H., Khari.na. J . M. and Loth, .J" ~ :Pyra.>:cle 
and induction of fatty liver by a single dose of ethanol, 
Science 168 : 1592-99 , 1970. 
Carlton, P.L. : Potentiation o~ the behavioral effec~b of 
amphetamine by .!.:-nipr9.mine. Psychopharmacologia. 2: J6l+-76, 
1961. 
96 
Chance, M.R.A.: The contribution of environment to unif0rmity. 
Coll. Pap. Lab. Anirn. Bur • .§.: 59-6 .3, 1957. 
Chance, M.R.A. and Mackintosh, J.H.: The effects of caging. 
Coll. Pap. Lab. Anirn. Bur. 11: 59-62, 1962. 
Consolo, s., Garrattini, S. and Valzelli, L.: Amphetamine 
toxicity in aggressive mice. J. Pharm. Pharmacol. 1:.1: 53-34 , 
1965. 
Crossland, J. and Leonard, B.E.: Barbiturate withdrawal 
convulsions in the rat. Biochem. Pharmacol. Suppl. 12: 103, 
1963. 
Curtis, D.R. and Watkins, J.C.: In Inhibition in the Nervous 
System and Gamma-Aminobutyric Acid. E. Roberts, C.F. 
Baxter, A. Van Harreveld, C.A.G. Wiserman, W.R. Adey and 
K.F. Killam (eds), pp. 424-444, Pergamon Press, New York, 
1960. 
Darling, R.C. and Roughton, F.J.: The effect of methemoglobin 
in the equilibrium between oxygen and hemoglobin. Arner. J. 
Physiol. lll: 56-58, 1942. 
Davidoff, R.A.: Gamma-amino butyric acid antagonism and pre-
synaptic inhibition in the frog spinal cord. Science 175.: 
331-32, 1972. 
Delorme, R., Fremont, J .L. and .Jouet, M.: Supression du 
sommeil par la p-chloromethamphetamine et la p-chloro-
phenylalanine. C.R. Soc. Biol. (Paris) 160: 2)47-51, 1966. 
Dixon, W.J. and Massey, F.J.: Introduction to statistical 
analysis. McGraw-Hill, New York, 1969, 3rd edition. 
Ebert, A.G., Yim, G. K. and Miya, T.: Distribution and 
metabolism of barbital cl4 in tolerant and non-tol€•rant; rats. 
Biochem. Pharmacol. !.J.: 1267-74 , 1964. 
Ehinger, B. and Falck, B.: Autoradiography 0 1~ some sus-
pected neurotransmitters substances: GABA, glyc i ne, glutamic 
acid, histamine, dopamine and 1-DOPA. Brain. Research .2.J.: 
157-72, 1971. 
Ellis, F.W., Pick, 
in rhesus monkeys. 
J.R.: Ethanol induced ~ithdrawal reactions 
Pharmacologist 1 1 : 25 6 , 1969. 
Essig, C.F.: Barbiturate ,.,-ithdr awal in whi te rats. 
Neuropharmacol. 2: lOJ-7, 1966. 
Int. J. 
Essig, C.F.: Clinical and experimental a s pects of b a rbitu-
rate withdrawa. l convulsions. Ep i lepsia 8: 21-30, 1967. 
Finley, T.N., Swensom, E .W., and Consroe, J.H., Jr.: The 
cause of arterial hypoxemia in patients with "alveolar-
capillary block S)!ldromc." J. Clin. Invest. 41: 618-25, 
1962. 
Folk, E.G.: Low pressure from terrestrial altitude. In: 
Introduction to Environmental Physiology. pp. 213-38, Lea 
and F'ebiger, Philadelphia , 1966. 
Freund, G.: 
Neurol. 21: 
Alcohol withdrawal syndrome in mice. 
315-20, 1969. 
Arch. 
Freund, G., and Walker, D.W.: Sound-induced seizures dur-
ing ethanol withdrawal in mice. Psychopharmacologia 22: 
45-49, 1971. 
Galindo, A., Krnjevic, K. and Schwartz, s.: Microiontophoric 
s~udies on neurons in the cuneate nucleus. J. Physiol. 
(Lond.) 192: J59-77, 1967. 
Garrattini, s., Giacolone, E., and Valzelli, L.: Isolation 
aggressiveness and 5-hydroxytryptamine turnoYer. J. Pharm. 
Pharmacol. 19: 338-39, 1967. 
Garrattini, S. and Jori, A.: Interactions between imipramine 
like drugs and reserpine on temperature. Iri: First Inter-
national Symposium on Antidepressant Drugs, Congress Series 
No. 122, ed. by s. Garrattini and M.N.G. Dukes, pp. 179-93, 
Excerpta Medica Fou..~dation, Amsterdam, 1967. 
Giacalone, E., Tansella, M., and Valzelli, L. and Garrattini, 
s.: Brain serotonin metabolism in isolated aggressive mice. 
Biochem. Pharmacol. 11.: 1315-27, 1968. 
Goldberg, L . a.nd Ryb~rg, V.: Inhil:ition of ethanol meta.bolism 
in vivo by administration of pyrazole. Biochem. Pharmacol. 
18: 1749-62, 1969. 
Goldstein, D.B., a~d Pal, N.: Alcohol dependence produced 
in r.lice by inhalation of ethanol: grading the withdrawal 
reaction. Science 172: 288-90, 1971. 
Gordon, E.R.: The effect of ethanol on the concentra~ion of 
1'-aminobutyric acid in the rat brain. Can. J. Physiol. 
Pharmacol. 45 : 915-18, 1967. 
Graham, L.T. and Aprison , M.H.: Fluorometric determination 
of aspartate, glutamate and -aminobutyrate in nerve 
tissue, usiP..g enzymic methods. Anc..l. Biochem. U: l~87-97 , 
1966. 
Guerrero-Figueroa, R., DeBalbian Verster, F., Barros, A. and 
Heath, R.G.: Cholinergic mechanism in s1ilicortical mirror 
focus and ei'f'ccts of' topical application of' GABA and acetyl-
choline. Epilepsia ~~ 140-55, 1964. 
97 
98 
Gurdjian, E.S., Webster, J.E. and Stone, W.E.: Cerebral 
constituents in relation to blood gases. Amer. J. Physiol. 
!..2.£: 149-157, 1949. 
Hagen, D. Q.: GABA levels in rat brain ai' ter prolonged ethanol 
intake. Quart. J. Stud. Ale. 28: 613-17, 1967. 
Hakkinen, H.M. and Kulonen, E.: The effect of ethanol on 
the aminoacids of the rat brain with refe rence to the admin-
istration of glutamine. Biochem. J. 1.§.: 588-93, 1961. 
Hakkinen, H.M. and Kulonen, E.: Comparison of various methods 
for the determination of GABA and other amino acids in rat 
brain with reference to ethanol intoxication. 
10: 489-94, 1963. 
J. Neurochem. 
Harvey, J.A.: Comparison between the effects of hypothalamic 
lesions on brain amine levels and drug action. J. Pharmacol. 
Exp. Ther. 141: 244-51, 1965. 
Harvey, J.A., Heller, A. and Moore, R.Y.: The effect of uni-
lateral and bilateral medial forebrain lesions on brain 
serotonin. J. Pharmacol. Exp. Ther. 140: 103-10, 1963. 
Harvey, J.A., Heller, A., Moore, R.Y., Howard, H.F., and 
Roth, L.J.: Effect of central nervous system lesons on 
barbiturate sleeping time in the rat. J. Pharmacol. Exp. 
Ther. 144: 24-36, 1964. 
Hatch, A., Balaz, T., Wiberg, G.S. and Grice, H.C.: Long term 
isolation stress in rats. Science 142: 507-12, 1963. 
Heller, A., Harvey, J.A., Hunt, H.F. and Roth, L.J.: Effect 
of lesions in the septal forebrain of the rat on sleeping 
time under barbiturate. Science 1.21:.: 662-63, 1960. 
Heller, A., Harvey, J.A. and Moore, R.Y.: A demonstration of 
fall in brain serotonin following central nervous system 
lesion in the rat. Biochem. Pharmacol. 11: 859-66, 1962. 
Heller, H., Hardan, G. and Zaidi, S.M.: Seasonal variation 
in the response of rats to the antidiuretic hormone. Brit. 
J. Pharmacol. 12: 100-5, 1957. 
Isbell, H., Altschul, S., Kornetsky, C.H., Eisenman, Anna J., 
Flanary, H.G. and Fraser, H.F.: Chronic barbiturate intoxi-
' cation: An experimental study. Arch. Neural. Psychiat. 
(Chicago) 64: 1-28, 1950. 
Iwama, K. and Jasper, H.H.: The action of gamma-amino 
butyric acid upon cortical electrical a c t ivity in the cat. 
J. Physiol. (Land.) LJS.: J6_5-80, 1957. 
99 
Jaffe, J.H. and Sharpless, S.K.: The rapid development of 
physical dependence on a barbiturate. J. Pharma~ol. Exp. 
Ther. 150: 140-45, 1965. 
Jori, A. and Garrattini, S.: Interaction between imipra-
mine-like agents and catecholamine-induced hyperthermia. 
J. Pharm. Pharmacol. l1,: 480-88, 1965. 
Jouvet, M.: Neuropharmacological basis for the role of 
5-HT in sleep mechanisms. Advanc. Pharmacol. 68: 267-69, 
1966. 
Killam, K.F. and Bain, J.A.: Convulsant hydrazides I: In 
vitro and in vovo inhibition of B6 enzymes by convulsant 
hydrazides. J. Pharmacol. Exp. Ther. 11.2.: 255-62, 1957. 
Kimbrell, G.M.: A preliminary analysis of the agonistic 
behavior patterns shown by three strains of mice, mus 
musculus, in the foot shock situation. Ph.D. Dissertation, 
Dept. Psychol., University of TeIUlessee, 1967. 
King, J.J., Chiun, G., Pum Lee, Y. and Visscher, M.B.: 
Single versus multiple occupancy and convulsion frequency 
in c3H mice. Proc. Soc. Exp. Biol. (N.Y.) 88: 661-63, 1955. 
Kobrin, S. and Seifter, J.: -amino acids and various bio-
genic amines as antagonists to pentylenetetrazole. J. 
Pharmacol. Exp. Ther. ~: 646-51, 1966. 
Kopeloff, L.M. and Chusid, J.G.: Pyridoxine and GABA as 
antagonists to drug induced convulsions in monkeys. J. 
Appl. Physiol. 20: 1JJ7-40, 1965. 
Kornetsky, C. and Mirsky, A.F.: On certain psychopharma-
cological and physiological differences between schizo-
phrenic and normal pa·c;ients. Psychopharmacologia 8: 
J09-l8, 1966. -
Kravitz, E.A., Molin.off, P.B. and Hall, Z.W.: A comparison 
of the enzymes and substrates of gamma-amino butyric acid 
metabolism in lobster excitatory and inhibitory axons. 
Proc. Natl. Ac ad. Sci. U. S • ..5±: 778-82 ,~ 1965. 
Krnjevic, K. and Schwartz, s.: Is gamma-aminobutyric acid 
an inhibitory transmitter? Na~ure 211: 1372-74, 1966, 
Lal, H., D~Feo, J.J., Pitterman, A., Patel, G. and Baumel, 
I.: Effects of prolonged social deprivation or enrichment 
o~ neuronal sensitivity for CNS depressants and stimulants. 
In: Drug Addict i on: Experimental Pharmacology, Vol. I, ed. 
by J. M. Singh, L . H. Miller and H. Lal, pp. 255-66, 
Futura Publishing Co., New York, 1972. 
100 
Lamar, C. Jr. and Sellinger, o.z.: T'ne inhibition in vivo 
of cerebral glutamine synthetase and glutamine transferase 
by the convulsant methionine sulphoximine. Biochem. 
Pharmacol. 14: 489 - 506, 1965. 
Lelbach, W.K.: Liver cell necrosis in rats after prolonged 
ethanol ingestion und e r the influence of an alcohol dehy-
drogenase inhibitor. Experientia (Basel) ,S2.: 816-18, 1969. 
Lester, D., Keokosky, w.z. and Felzenberg, F.: Effect of 
pyrazole and other compounds on alcohol metabolism. Quart. 
J. Stud. Ale • .s!_: 449-54, 1968. 
Lieber, c.s., Rubin, E ., DeCarli, L.M., Mirsa, P. and Gang, 
H.: Effects of pyrazole on hepatic function and structure. 
Lab. Invest. 22: 61.5-21, 1970. 
Lowry, O.H., Rosenbrough, N.J., Farr, A.L. and Randall, R.J.: 
Protein meas.urement with the f'olin phenol reagent. J. Biol. 
Chem • .!2..2: 265-75, 1951. 
Lundquist, F.: The determination of ethyl alcohol in blood 
and tissues. Methods Biochem. Anal. 1: 217-51, 1959. 
McQuarrie, D.G. and Fingl, E.: Effects of' single doses and 
chronic administration of' ethanol on experimental seizures 
in mice. J. Pharmacol. Exp . Ther. 124: 264-71, 1958. 
Morgan, J.C. and DiLuzio, N.R.: Inhibition of' the acute 
ethanol induced fatty liver by pyrazole. Proc. Soc. Exp. 
Biol. Med. 1..Jl±.: 462-66, 1970. 
Norton, P.R.E.: The effects of drugs on barbiturate with-
drawal convulsions in the rat. J. Pharm. Pharmacol. 22: 
763-66, 1970. 
Oba ta, K., Ito, M., Ochi, R. and Sato, N.: Pharmacologic 
properties of' the post synaptic inhibition by purkinje 
cell axons and the action of gamma-amino butyric acid on 
Deiters neurons, Exptl. Brain. Res. 4: 4J-57, 1967. 
Oja, S.S.~ Oja, H. and Sarajas, H.S.S.: Cerebral free 
amino acids in the rats undergoing varying periods of an-
aesthesia and hypothermia. Ann . Acad. Sci . FerJl. Ser. A II 
Chem. 142: J-14 1 1968. 
Oswald, S. and Fry, J.: Diseases of the respiratory system, 
F.A. Davis Co., Philadelphia , 19~2. 
Otsuka, M.: GARA and scme other trar:smitter candidates in 
the nervous system. Fifth Int. Cong. Pharmaco 1. Abstracts 
of' Invited Pr.:;sentat.ion.s; pp. 16-17, 1972. 
101 
Otsuka, M., Iverson, L.L., Hall, z.w. and Kravitz , E.A .: 
Release of gamma-amino butyric acid from inhibitory nerves 
of lobster. Proc. Natl. Acad. Sci. u. s.: 2§.: 1110-15, 1966. 
Pasquini, J.M., Salomane, J.R. and Gomez, C.J.: Amino acid 
changes in the mouse brain during audiogenic and recovery. 
Exp. Neurol. 21: 245-56, 1968. 
Pisano, J.J. and Udenfriend, S.: Fo-rmation of guanide-
butyric acid and guanido-acetic acid in brain. Fed. Proc. 
TI: 403, 1958. 
Purpura, D.P., Giardo, M. and Grundfast, H.: Selective 
blockade of excitatory synapses in the cat brain by 
gamma-amino butyric acid. Science 1.,gj_: 1200-2, 1957. 
Rech, R.H. and Domino, E.F.: Effects of gamma-amino butyric 
acid on chemically and electrically evoked activity in the 
isolated cerebral cortex of the dog. J. Pharmacol. Exp . 
'I'her. 12.Q.: 59-67, 1960. 
Roberts, E.: Formation and liberation of' gamma-amino 
butyric acid in brain. In: Progress in Neurobiology . I. 
Neurochemistry. ed. by S. R. Korey and J. I. Nurnberger . 
pp. 11-25, Roeber-Harper, New York, 1956. 
Roberts, E . and Frankel, S.: Gamma-amino butyric acid in 
brain. Its formation from glutamic acid • . J. Biol. Chem. 
187: 55-63, 1950. 
Roberts, E. and Frankel, S .: Further studies of glutamic 
acid decarboxyalse in brain. J. Biol. Chem. 190: 505-12, 
1951. 
Roberts, E. and Kuriyama, K.: Biochemical physiological 
correlations in studies of the gamma-amino butyric acid 
system. Japan. Life Sci. Tokyo (Seitai-no-Kagaku) 1...2,: 
2-27, 1967, Brain Res. 18: 1-35. 
Roberts, E. and Simonsen, D.G.: Some properties of 1-glu~ 
tamic acid ::lecarboxylase in mouse Lrai:!l . Bio-:hem. Phar:nacol. 
12: 113-34, 1963. 
Robinson, s.M., Blatt, W .F., Schatz, R. and Joy, R.: The 
ef'f'ects of' simulated altitude and aggregation en r..exobarb-
i tal sleeping time itl mice. Fed. Proc • .?:1.: 282, 1968 . 
Roth, B.F. and Harvey, J.A.: Altered response of' cerebral 
respiration to thiopental and pot2.ssium ions in vi l:;ro after 
septal lesions. J. Pharmacol . Exp. Ther. 161: 155-62, 1968. 
Rubin, E ., Gang, H. and Liebe~, c.s. : Interaction of ethanol 
and pyrazole with hepatic microsomes. Biochem . Biophys. 
Res. Commun. 42: l-8, 1971 . 
102 
Salganicoff, L. and DeRobertis, E.: Subcellular distribu-
tion of the enzyme of the glutamic acid, glutamine and 
gamma-amino acid cycles in rat brain. J. Neurochem. 12: 
287-309, 1965. 
Salvador, R.A. and Albers, R.W.: The distribution of glu-
tamic -i-aminobutyric transaminase in the nervous system 
of the rhesus monkey. J. Biol. Chem. ~: 922-25, 1959. 
Schatz, R.A. and Lal, H.: Elevation of brain GABA by 
pargyline: a possible mechanism for protection against oxy-
gen toxicity. J. Neurochem. 18: 2553-55, 1971. 
Schlesinger, K., Boggan, w. and Freedman, D.X.: Genetics 
of audiogenic seizures: II Effects of pharmacological 
manipula~ion of brain serotonin, norepinephrine and gamma-
amino butyric acid. Life Sci. 1: 437-47, 1968. 
Seguin, J.J. and Stavraky, G.W.: The effec~s of barbitu-
rates on partially isolated region of the central nervous 
system. Canad. J. Biochem. Physiol. J..2.: 667-80, 1957. 
Shah, H. and Lal, H.: The potentiation of barbiturates by 
desipramine in the mouse: mechanism of action. J. 
Pharmacol. Exp . Ther. 112.: 404-9, 1971. 
Sigg, E.B., Day, C.A. and Colombo , c.: Endocrine factors 
in isolation-induced aggressiveness in rodents. Endo-
crinology 1§.: 679-84, 1966. 
Simpson, J.R., Grabarits, F. and Harvey, J.A.: Differential 
effects of central nervous system lesions on brain amines 
and reserpine action in the rat. Pharmacologist ~: 213, 
1967. 
Sjoqvist, F . and Gillette, J.: Prolongation and potentia-
tion of oxotremorine effect~ by desmethylimipramine, an 
"anti-tremorine" drug. Life Sci. 4: 1031-36, 1965. 
Sorenson, J.P. and Harvey, J.A.: Decreased brain acetyl-
choline after septal lesions in rats: correlation with 
thirst. Physiology and Behavior 6: 723-725, 1971. 
Stevenson, I.H. and Turnbull, H.J.: The sensitivity of the 
brain to barbiturate during chronic administration and 
withdrawal of barbitone sodium in the rat. Br. J. 
Pharmacol. J.2..: 325-333, 1970. 
103 
Takeuchi, A. and Takeuchi, N.: Localized action of gamma-
a.mino butyrj_c acid on the crayfish muscle. J. Physiol. 
(Land.) 1J.1.: 225-38, 1965. 
Tallan, H.H., Moore, s. and Stein, W.H.: Studies on the free 
aminoacids and related compounds in the tissues of cat. 
J. Biol. Chem. 211: 927-J9, 1954. 
TI1eorell, H., Yonetani, T. and Sjoberg, B.: On the effects 
of some heterocyclic compounds on enzymic activity of 
liver alcohol dehydrogenase. Acta Chem. Scand • .si: 255-60, 
1969. 
Udenfriend, S.: Identification of gamma-amino butyric acid 
in brain by isotope derivitive method. J. Biol. Chem. 187: 
65-69, 1950. 
Valzelli, L. and Garrattini, S.: Behavioral changes and 
serotonin. turnover in animals. Advanc, Pharmacol. 6B: 
249-60, 1969. --
Van Liere, E.J. and Stickney, J.C.: Hypox1a, University of 
Chicago Press, Chicago, 196J. 
Wahlstrom, G.: Hexobarbital (enhexymalian NFN) sleeping 
times and EEG threshold doses as measurements of tolerance 
to barbit~rates in the rat. Acta Pharmacol. {Kbh.) 26: 
6!4--80, 1968. 
Wahlstrom, G.: Changes in hexobarbital anaesthesia threshold 
in rats ind· . lced by repeated long term treatment wj, th 
barbital or ethanol. Psychopharmacologia .!2.: J66-80, 1971. 
Wallach, D.P.: Studies on the GABA pathway-I. Biochem. 
Pharma.col. 2: J2J-Jl, 1961. 
Welch, A.S. and Welch, B.L.: Effects of stress and p-chloro-
phenylalanine upon brain serotonin, 5-hydroxyindoleacetic 
acid and catecholamines in grouped arid i!3olated mice. 
Bio chem. Pharn!acol. g: 699-708, 1968. 
Wenzel, D.G. and Lal, H.: The relative reliability of the 
escape reaction and righting reflex sleeping tines in the 
mouse. J. Arner. Phar. Assoc. (Sci. ed.) 48: 90-91, 1959. 
Wiechert, P. and Herbst, A.: Provocatio~ 0f cerebral 
seizures by derangement of the natural bal ance betwe e n 
glutamic acid and -amino lmtyric acid. J. Neurochern. 1..J.: 
59-64, 1966. 
Wolfe, L.S. and Elliot, K.A.C.: Chemical studies in rela-
tion to convulsive disorders. In: Neurocnemis-t.ry, ed. by 
K.A.C. Elliott, I.H. Page and J.H. Quastel, pp. 694-727. 
Charles C. Thomas, Springfield, Illinois, 1962. 
104 
Wood, J.D. and Watson, W.J.: Gamma- amino butyric acid levels 
in the brain of rats exposed to oxygen at high pressure. 
Can. J. Biochem. Physiol. 41 : 1907-13, 1963. 
Wood, J.D., Watson, W.J. and Drucker, A.J.: Oxygen poisoning 
in various marruualian species and the possible role of GABA 
metabolism. J. Neurochem. }_~: 1067-74, 1967. 
Wood, J.D., Watson, W.J. and Drucker, A.J. : The effects of 
hypoxia on brain GABA levels. J. Neurochem. 12.= 603-8, 1968. 
Yen, C.Y., Stanger, R.L. and Millman , N.: Ataractic suppres-
sion of isolation-induced aggression behavior. Arch. Int. 
Pharmacodyn. 1.Sl: 179-85, 1959. 
Zuromski, E.s., Donovick, P.J. and Burright , R.G.: Bar-
pressing for illumination change in albino rats with septal 
lesions. J. Comp. Physiol. Psychol. 1§.: 83-90, 1972. 
